A Longitudinal Investigation of Interpersonal Trauma Exposure, Posttraumatic Stress Disorder, and Cannabis Use Phenotypes among College Students by Hicks, Terrell A.
Virginia Commonwealth University 
VCU Scholars Compass 
Theses and Dissertations Graduate School 
2019 
A Longitudinal Investigation of Interpersonal Trauma Exposure, 
Posttraumatic Stress Disorder, and Cannabis Use Phenotypes 
among College Students 
Terrell A. Hicks 
Follow this and additional works at: https://scholarscompass.vcu.edu/etd 
 Part of the Clinical Psychology Commons 
 
© Terrell A. Hicks 
Downloaded from 
https://scholarscompass.vcu.edu/etd/6066 
This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has 
been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. 
For more information, please contact libcompass@vcu.edu. 
 
 
 
A Longitudinal Investigation of Interpersonal Trauma Exposure, Posttraumatic Stress Disorder,  
 
and Cannabis Use Phenotypes among College Students  
 
 
 
 
 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science  
 
at Virginia Commonwealth University 
 
 
 
 
 
 
By: Terrell Alexander Hicks 
 
Bachelor of Science, University of North Carolina at Chapel Hill, 2014 
 
 
 
 
 
 
Direction: Ananda B. Amstadter, Ph.D. 
 
Associate Professor 
 
Departments of Psychiatry, Psychology, and Human and Molecular Genetics 
 
 
 
 
 
 
Virginia Commonwealth University 
 
Richmond, VA 
 
Thursday, November 21, 2019 
 
 
2 
Table of Contents 
 
ABSTRACT .................................................................................................................... 4 
STATEMENT OF THE PROBLEM.............................................................................. 7 
LITERATURE REVIEW ............................................................................................... 8 
PREVALENCE OF CANNABIS USE PHENOTYPES ............................................................... 8 
SEX AND CANNABIS USE PHENOTYPES ........................................................................ 11 
RACE, ETHNICITY, AND CANNABIS USE PHENOTYPES .................................................. 12 
AGE AND CANNABIS USE PHENOTYPES ....................................................................... 13 
Cannabis Use Phenotypes among College Students ................................................ 15 
SUMMARY: CORRELATES OF CANNABIS USE PHENOTYPES ........................................... 17 
PREVALENCE AND CORRELATES OF TRAUMA EXPOSURE AND PTSD ............................ 17 
Trauma Exposure and PTSD among College Students ............................................ 22 
PTSD AND SUD COMORBIDITY .................................................................................. 23 
TRAUMA EXPOSURE, PTSD, AND CANNABIS USE PHENOTYPES ................................... 24 
THE SELF-MEDICATION HYPOTHESIS .......................................................................... 26 
THE HIGH-RISK AND SUSCEPTIBILITY HYPOTHESES ..................................................... 28 
SHARED RISK MODEL ................................................................................................. 29 
SUMMARY .................................................................................................................. 31 
CURRENT STUDY ...................................................................................................... 32 
METHODS .................................................................................................................. 33 
PARTICIPANTS ............................................................................................................ 33 
MEASURES ................................................................................................................. 33 
Demographics ........................................................................................................ 34 
Cannabis Use ......................................................................................................... 35 
Interpersonal Trauma Exposure (IPT) .................................................................... 35 
Probable PTSD ...................................................................................................... 36 
Alcohol Use Frequency ........................................................................................... 36 
Nicotine Use Frequency.......................................................................................... 37 
DATA ANALYTIC PLAN ............................................................................................... 37 
Multiple Imputation ................................................................................................ 37 
Overview of Data Analytic Plan .............................................................................. 38 
Determination of Statistical Significance ................................................................ 38 
Aim 1 Analyses ....................................................................................................... 38 
AIM 1 RESULTS ......................................................................................................... 39 
AIM 1 PARTICIPANT CHARACTERISTICS ....................................................................... 39 
PREVALENCE ESTIMATES OF LIFETIME CANNABIS, NICOTINE, AND ALCOHOL USE ....... 42 
PREDICTORS OF LIFETIME EXPERIMENTAL AND PROBLEMATIC CANNABIS USE ............. 42 
POST-HOC ANALYSES ................................................................................................. 48 
PREVALENCE ESTIMATES OF LIFETIME INTERPERSONAL TRAUMA EXPOSURE ............... 51 
PREDICTORS OF LIFETIME INTERPERSONAL TRAUMA EXPOSURE .................................. 51 
DATA ANALYTIC PLAN: AIMS 2 AND 3 ................................................................. 55 
 
 
3 
AIMS 2 AND 3 ANALYSES ............................................................................................ 55 
DETERMINATION OF MODEL FIT .................................................................................. 57 
AIMS 2 AND 3 PARTICIPANT CHARACTERISTICS ........................................................... 57 
AIM 2 RESULTS ......................................................................................................... 57 
AIM 2 MODEL FIT ....................................................................................................... 60 
AIM 2 OUTLIER ANALYSES ......................................................................................... 60 
ASSOCIATION BETWEEN YEAR 1 FALL IPT AND YEAR 1 SPRING CANNABIS USE ............ 60 
ASSOCIATION BETWEEN YEAR 1 FALL CANNABIS USE AND YEAR 1 SPRING IPT ............ 61 
AIM 3 RESULTS ......................................................................................................... 64 
AIM 3 MODEL FIT ....................................................................................................... 64 
AIM 3 OUTLIER ANALYSES ......................................................................................... 64 
MEDIATIONAL ASSOCIATION BETWEEN IPT, PROBABLE PTSD, AND CANNABIS USE ...... 64 
MEDIATIONAL ASSOCIATION BETWEEN CANNABIS USE, IPT, AND PROBABLE PTSD ...... 66 
AIM 1 DISCUSSION ................................................................................................... 69 
AIM 1A: OVERALL SUMMARY OF FINDINGS ................................................................. 69 
PREVALENCE OF LIFETIME CANNABIS USE .................................................................. 70 
PREDICTORS OF LIFETIME CANNABIS USE ................................................................... 70 
AIM 1B: OVERALL SUMMARY OF FINDINGS ................................................................. 73 
PREVALENCE OF LIFETIME IPT EXPOSURE................................................................... 74 
PREDICTORS OF LIFETIME IPT EXPOSURE .................................................................... 74 
AIM 2 DISCUSSION ................................................................................................... 77 
AIM 2: OVERALL SUMMARY OF FINDINGS ................................................................... 77 
SELF-MEDICATION HYPOTHESIS ................................................................................. 77 
HIGH-RISK HYPOTHESIS ............................................................................................. 79 
AIM 3 DISCUSSION ................................................................................................... 80 
AIM 3: OVERALL SUMMARY OF FINDINGS ................................................................... 80 
SELF-MEDICATION HYPOTHESIS ................................................................................. 81 
HIGH-RISK HYPOTHESIS ............................................................................................. 82 
LIMITATIONS ............................................................................................................ 84 
IMPLICATIONS AND FUTURE DIRECTIONS ....................................................... 85 
CONCLUSION ............................................................................................................ 87 
REFERENCES ............................................................................................................ 89 
APPENDIX ................................................................................................................ 112 
 
 
  
 
 
4 
Abstract 
College students have an increased risk for cannabis use, trauma exposure, and posttraumatic 
stress disorder (PTSD). Cannabis use disorder (CUD) and PTSD comorbidity is high, and given 
the negative consequences of the comorbidity (e.g., poor academic outcomes), there is a need to 
understand comorbid CUD-PTSD etiology. Two primary etiologic models exist: self-medication 
(i.e., PTSD à CUD) and high-risk (i.e., CUD à PTSD) hypotheses. This study 1) examined the 
prevalence and predictors of cannabis use and interpersonal trauma (IPT) exposure; 2) 
investigated the relationship between cannabis use and IPT; and 3) examined cannabis use, IPT, 
and PTSD through mediational self-medication and high-risk hypotheses lenses in a large (n = 
9,889) longitudinal study of college students. Aim 1 found the prevalence of lifetime problematic 
(i.e., use ≥ 6 times) and experimental (i.e., use 1-5 times) cannabis use was 28.3% and 17.4%, 
respectively. Aim 1 results also estimated that the prevalence of lifetime IPT exposure was 
35.9%. Aim 2 results supported the self-medication hypothesis, but not the high-risk hypothesis. 
Overall model fit from Aim 3 was poor. Nonetheless, Aim 3 results did not support the self-
medication or high-risk hypotheses. Given the poor model fit of Aim 3, results should be 
interpreted with caution. However, as a whole, these findings provide preliminary support for the 
self-medication hypothesis, indicating that those reporting IPT exposure and probable PTSD may 
be at risk for cannabis use. Implications of these findings, in light of study limitations, are 
discussed. 
Keywords: cannabis, substance use, trauma, interpersonal trauma, posttraumatic stress disorder 
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Statement of the Problem 
Public support for the legalization of cannabis is increasing (Kilmer & MacCoun, 2017), 
which may be contributing to the high prevalence of use. Indeed, cannabis is the currently most 
widely used illicit substance in the United States (U.S.) (Substance Abuse and Mental Health 
Services Administration, 2016). Cannabis use and cannabis use disorder (CUD) are common in 
the general population, and among college students (Hasin et al., 2016; Johnston, O’Malley, 
Bachman, Schulenberg, & Miech, 2016). Of concern, cannabis use is higher among college 
students than their same-age, non-college peers (Johnston et al., 2016). Most long-term adverse 
effects of cannabis use are more likely among heavy or chronic users, but short-term adverse 
effects can affect anyone regardless of frequency of use (Hall & Degenhardt, 2009; Kalant, 
2004). Functional short-term consequences of cannabis use include neurocognitive impairment 
(i.e., problems with psychomotor function, attention, memory, and learning), which can 
negatively affect the large number of individuals who use cannabis occasionally or moderately. 
Thus, the identification of etiological factors associated with cannabis use and CUD, particularly 
among high-risk populations such as college students, are needed to inform prevention and 
intervention programming.  
Two key potential factors associated with cannabis use that warrant increased study are 
trauma exposure and posttraumatic stress disorder (PTSD), both of which are common among 
college students (Netto et al., 2013; Read, Ouimette, White, Colder, & Farrow, 2011; Scarpa et 
al., 2002; Vrana & Lauterbach, 1994). In addition, college students are also at higher risk for 
certain types of traumatic events that have a high likelihood of leading to PTSD, such as 
interpersonal trauma (IPT) (Anders, Frazier, & Shallcross, 2012; Anders, Shallcross, & Frazier, 
2012; Edwards, Catling, & Parry, 2016). Epidemiological and acute trauma studies suggest that 
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trauma exposure and PTSD are associated with cannabis use and CUD and that PTSD and CUD 
frequently co-occur (Cougle, Bonn-Miller, Vujanovic, Zvolensky, & Hawkins, 2011; Kevorkian 
et al., 2015; Vlahov et al., 2002). 
There are numerous phenotypic models posited to explain comorbid PTSD and CUD. 
Co-occurrence of these two conditions may begin when a person attempts to self-medicate their 
PTSD symptoms (Chilcoat & Breslau, 1998), or CUD could lead to PTSD if the person 
experiences trauma caused by their cannabis use (Chilcoat & Breslau, 1998), like a car accident 
or physical violence. There is a need for empirical investigation of these models explaining 
comorbid PTSD and CUD particularly as public support for the legalization of cannabis is 
increasing (Kilmer & MacCoun, 2017), which may further increase cannabis use. 
The increasing prevalence of cannabis use and its adverse health effects combined with 
an increased risk for trauma exposure among college students makes the intersection of CUD and 
PTSD an area in need of future research. Indeed, etiologic models of CUD and PTSD have not 
been fully elucidated. Limited epidemiological studies are available on the association between 
CUD and PTSD specifically, as most studies have examined the co-occurrence of PTSD and 
other substance use disorders such as alcohol use disorder or tobacco use disorder (Debell et al., 
2014; Fu et al., 2007). Even fewer have examined the association between cannabis use and post-
trauma phenotypes longitudinally which will allow for testing of direction of causation between 
these conditions. 
Literature Review 
Prevalence of Cannabis Use Phenotypes 
Cannabis has been the most commonly used illicit substance in the U.S. for several 
decades (Johnston, O'Malley, Bachman, & Schulenberg, 2006; Rouse, Sanderson, & Feldmann, 
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2002). According to the U.S. National Survey on Drug Use and Health (NSDUH) 2015 annual 
report, the lifetime prevalence of cannabis use was 44% (approximately 117.9 million people) 
and cannabis use in the past month increased from 6.2% in 2002 to 8.3% (approximately 22.2 
million people) in 2015 among people aged 12 or older (Substance Abuse and Mental Health 
Services Administration, 2016). Research suggests that about 10% of those who ever use 
cannabis become daily users, and about 20% to 30% become weekly users (Hall & Pacula, 
2003). Individuals who use cannabis weekly or more have an increased risk for developing a 
substance use disorder (SUD) than experimental users (Swift, Coffey, Carlin, Degenhardt, & 
Patton, 2008). 
While the majority of cannabis use remains recreational, a notable number of individuals 
go on to develop CUD, a disorder characterized by the harmful consequences of repeated 
cannabis use, a pattern of compulsive cannabis use, and in some cases physiological dependence 
on cannabis (i.e., tolerance and/or symptoms of withdrawal) (American Psychiatric Association, 
2013). CUD is only diagnosed when cannabis use becomes persistent and causes significant 
academic, occupational or social impairment. CUD in Diagnostic and Statistical Manual of 
Mental Disorders (DSM-5) combines the DSM-IV categories of cannabis abuse and dependence 
into a single disorder measured on a continuum from mild to severe. In addition to the DSM-IV 
abuse and dependence diagnoses being combined into a singular diagnosis for DSM-5 CUD, the 
symptom of recurrent legal problems has been removed, and the symptom of craving or a desire 
or urge to use cannabis has been added. Given the numerous changes in criteria, comparing 
prevalence of CUD to the prior abuse and dependence diagnoses is difficult. For example, 
whereas a diagnosis of DSM-IV cannabis abuse previously required only one symptom, mild 
cannabis use in DSM-5 requires two to three symptoms from a list of 11. Therefore, it is 
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currently more difficult to reach the threshold for DSM-5 CUD than DSM-IV. A study published 
using the National Epidemiological Survey on Alcohol and Related Conditions (NESARC) data 
in 2011 estimated an 8.9% cumulative probability of developing lifetime cannabis dependence 
based on DSM-IV criteria for substance dependence among individuals who reported any history 
of cannabis use (Lopez-Quintero et al., 2011). In an epidemiological study estimating the 
prevalence of DSM-IV cannabis abuse and dependence among a large nationally representative 
sample of U.S. adults, Stinson and colleagues (2006) found the prevalence of lifetime (8.5%) and 
12-month (1.5%) CUD (i.e., abuse or dependence). More specifically, the prevalence of 12-
month (1.1%) and lifetime (7.2%) DSM-IV cannabis abuse surpassed the rates of 12-month 
(0.3%) and lifetime (1.3%) cannabis dependence (Stinson et al., 2006). 
Multiple lines of evidence support the conclusion that cannabis use is on the rise. One 
study analyzed Veteran Administration medical record data and found an increase of about 50% 
in CUD with co-occurring SUDs from 2002 to 2009 and an increase of 115% in CUD without 
other SUDs during the same time period (Bonn-Miller, Harris, & Trafton, 2012). Using data on 
illicit substances involved with fatally injured motor vehicle accidents in U.S. emergency 
hospital visits from 2004 to 2011, researchers found a 62% increase in cannabis use (Brady & Li, 
2014). Additionally, another study analyzing cannabis metabolites of individuals with the 
Fatality Analysis Reporting System from 1999 to 2010 reported a 200% increase in cannabis use 
(Drug Abuse Warning Network, 2011). Analyzing data collected from three cross-sectional adult 
surveys (e.g., the 1991-1992 National Longitudinal Alcohol Epidemiologic Survey, the 2001-
2002 NESARC, 2012-2013 NESARC–III), Hasin and colleagues (2017) concluded that states 
that allow medicinal cannabis use have an increased risk for cannabis use and CUD. 
Additionally, rates of cannabis use and CUD are increasing at a significantly greater rate in states 
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that allow medicinal cannabis use than in states that do not (Hasin et al., 2017). Given the high 
prevalence of cannabis use in the U.S. population, it is critical to examine factors that are related 
to use and the transition from use to problematic use (e.g., daily, weekly, or heavy use; CUD) in 
order to inform effective prevention and intervention programming.  
Sex and Cannabis Use Phenotypes 
 Generally, extant studies suggest that men are more likely to use cannabis than women, 
and the differences tend to be most stark at higher frequency levels. Based on a longitudinal 
nationally representative sample of high school graduates in the U.S. from 1975 to 2015, the sex 
gap has averaged about 5 to 9 percentage points for 19- to 30-year olds since 1995 (Johnston et 
al., 2016). Additionally, daily cannabis use levels were more than twice as high for men than 
women (8.1% versus 3.8%) in 2015 (Johnston et al., 2016). The NSDUH found that the 
prevalence of past-year cannabis use increased for both men (+4.0%) and women (+2.7%) from 
2002 to 2014 (Carliner et al., 2017). Increases were greater for men (+4.4%) than women 
(+2.7%) between 2007 and 2014, leading to a widening of the sex gap over time (Carliner et al., 
2017). Both the growing positive public perception and increasing rates of cannabis use likely 
play a role in cannabis being the drug with the highest rate of problematic use regardless of sex 
in the U.S. (Substance Abuse and Mental Health Services Administration, 2016). 
 Similar to cannabis use, patterns of CUD mirror those of past-year and daily cannabis use 
in terms of sex. Based on results from the 2001-2002 NESARC, the prevalence of lifetime CUD 
was higher in men (11%) than women (5%) (Khan et al., 2013). Additionally, men were using at 
higher quantities per day compared to women (3.38 versus 2.54 joints per day) and the average 
duration of the longest episode of CUD was higher in men compared to women (40.43 versus 
31.01 weeks) (Khan et al., 2013). Findings from the 2012-2013 NESARC-III were comparable 
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to results from the 2001-2002 NESARC, which suggests that the sex gap is not widening in 
terms of CUD as it is with past-year cannabis use (Hasin et al., 2016). Men were 2.2 times more 
likely than women to meet DSM-5 criteria for any severity of past 12-month CUD. Additionally, 
men were 2.8 times more likely to meet DSM-5 criteria for past 12-month severe CUD than were 
women, 1.8 times more likely for moderate CUD, and 2.2 times more likely for mild CUD 
(Hasin et al., 2016). Men were 2.1 times more likely than women to meet DSM-5 criteria for 
lifetime CUD. Additionally, men were 2.4 times more likely to meet DSM-5 criteria for lifetime 
severe CUD than were women, 2.1 time more likely for moderate CUD, and 1.9 times more 
likely for mild CUD (Hasin et al., 2016). Collectively, these findings suggest that there may be 
sex-specific pathways that influence the initiation of cannabis use and the development of CUD. 
Thus, it is important to consider sex-specific patterns of cannabis use and CUD in future 
research. Similar to sex, race and ethnicity are other un-modifiable factors that contribute to an 
individual’s risk for cannabis use and CUD. 
Race, Ethnicity, and Cannabis Use Phenotypes 
Generally, research shows that African-American and Hispanic individuals are more 
likely to use cannabis than other racial/ethnic groups (Pacek, Malcolm, & Martins, 2012; 
Warner, 2016). All racial/ethnic groups saw an increase in cannabis use across the 2001-2002 
NESARC and 2012-2013 NESARC-III, but the difference was higher for certain groups (Hasin 
et al., 2015). Specifically, significant increases in cannabis use were seen among Caucasian 
(4.1% versus 9.4%), African-American (4.7% versus 12.7%), Native American (7.0% versus 
17.1%), and Hispanic (3.3% versus 8.4%) individuals (Hasin et al., 2015). Trends in cannabis 
use from 1999-2013 among a national sample of U.S. high school students mirror national 
prevalence estimates for adults (Johnson et al., 2015). By 2013, four of the seven racial/ethnic 
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groups had a prevalence of current cannabis use that exceeded 25%: African-American (29%), 
Hispanic (28%), American-Indian (36%) and Multi-Racial individuals (29%), whereas the 
prevalence of use was lower among Caucasian individuals (22%) and Asian-American 
Individuals (11%) (Johnson et al., 2015). Similar to cannabis use, the rates of past 12-month 
DSM-IV CUDs increased among African-American (1.8% versus 4.6%) and Hispanic (1.2% 
versus 2.8%) individuals (Hasin et al., 2015). Higher levels of cannabis use among African-
American, Hispanic, and American-Indian individuals deserve public health attention because 
these groups are more likely than Caucasian individuals to experience negative consequences of 
cannabis use, including CUD and negative psychosocial outcomes (Edwards, Bunting, & Garcia, 
2015). Thus, it is important to consider both racial- and ethnic-specific patterns of cannabis use 
and CUD in future research. 
Age and Cannabis Use Phenotypes 
Generally, research shows that individuals between the ages of 18- and 25-years old are 
more likely to use cannabis compared to older adults (Suerken et al., 2014). Based on results 
from the 2012-2013 NESARC, the prevalence of past-year cannabis use was highest among 18- 
to 29-year olds (21%) and decreased with age (30- to 34-year olds (10%), 45- to 64-year olds 
(6%), 65-year olds and older (1%) (Hasin et al., 2015). Similarly, according to the 2015 
NSDUH, cannabis use is most prevalent among young individuals ages 18- to 25-years old, with 
an estimated 19.8% using in the past month (Center for Behavioral Health Statistics and Quality, 
2014). Not surprisingly, estimated prevalence of CUD among age groups follows a similar 
pattern as cannabis use. Based on results from the 2012-2013 NESARC, the prevalence of DSM-
IV past-year CUDs (e.g., abuse or dependence) was highest among 18- to 29-year olds (7.5%) 
and decreased with age (30- to 34-year olds (2.9%), 45- to 64-year olds (1.3%), 65-year olds and 
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older (0.3%)) (Hasin et al., 2015). Despite DSM-5 no longer distinguishing between DSM-IV 
cannabis abuse and dependence, the list of DSM-5 CUD symptoms are nearly identical to DSM-
IV cannabis abuse and dependence. Therefore, rates of CUD remain relatively similar across the 
two diagnostic rubrics. According to the 2012-2013 NESARC adjusted for DSM-5 criteria, 6.9% 
and 11% of 18- to 29-year olds, 2.5% and 7.4% of 30- to 44-year olds, 0.8% and 3.7% of 45-year 
olds and older met DSM-5 criteria for 12-month CUDs (mild, moderate, or severe) and lifetime 
CUD, respectively (Hasin et al., 2016). In summary, recent epidemiologic studies show that 
young adults were found to be at highest risk for cannabis use and CUD when examined by age, 
and also suggest that the average age of onset is around the same timeframe. 
Based on two epidemiological studies (Hasin et al., 2016; Stinson et al., 2006), the 
average age of onset for CUD appears to be during young adulthood. The average ages of onset 
for DSM-IV cannabis abuse and dependence were 19.3-years old and 19.0-years old, 
respectively (Stinson et al., 2006). Based on the 2012-2013 NESARC, the average age at onset 
of DSM-5 CUD was 21.7 years-old (Hasin et al., 2016). Thus, the estimated average age of onset 
of CUDs overlaps with an important developmental period for most individuals—college. 
College students have become an important population to study in order to prevent public health 
problems, especially drug use, because of its size (estimated 20.4 million students in American 
colleges and universities in Fall 2017) and critical age range (average age range of 18- to 24-
years old) (National Center for Education Statistics & US Department of Education, 2016).  
Approximately one-third of young adults between the ages of 18- and 24-years old are enrolled 
in post-secondary education (National Center for Education Statistics & US Department of 
Education, 2016). The college years represent a particularly important developmental phase. 
Most students are away from home for the first time without parental supervision and are trying 
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to adjust, socialize, and fit in. In addition to adjusting to being away from home, students are 
attending parties with alcohol and other illegal substances, which makes college a potentially 
dangerous period. Therefore, college students are more vulnerable to new, sometimes prohibited 
or illicit, experiences (Leibsohn, 1994; Walsh, 1992). A number of epidemiologic studies suggest 
that the prevalence of CUD is highest among young adults (Center for Behavioral Health 
Statistics and Quality, 2014; Hasin et al., 2016; Hasin et al., 2015; Suerken et al., 2014), and also 
suggest that the age of onset of CUD is in young adulthood (Hasin et al., 2016). Thus, it is 
critical to consider age-specific patterns of cannabis use and CUD in future research as well as 
study cannabis use and CUD among college students and how changes in their environment 
influence use. 
Cannabis Use Phenotypes among College Students. Postsecondary education has 
become all but required for a well-paying career in today’s economy and, as a result, college 
enrollment rates are skyrocketing. Between 2000 and 2015, the 18- to 24-year-old population 
rose from approximately 27.3 million to nearly 31.2 million (National Center for Education 
Statistics & US Department of Education, 2016). Likewise, the estimated number of 18- to 24-
year olds enrolled in college also rose from approximately 15.3 million to nearly 19.9 million 
between 2000 and 2015 (National Center for Education Statistics & US Department of 
Education, 2016). In a sample of 3,146 college students from 11 colleges and universities in 
North Carolina and Virginia, nearly 30% of students reported using cannabis prior to enrolling in 
college (Suerken et al., 2014). Suerken and colleagues (2014) also found that 8.5% of college 
students who did not use cannabis prior to starting college initiated use during freshman year. As 
of 2016, the Monitoring the Future survey results revealed that 1 in 5 college students will 
become first-time users of cannabis during their time in college (Johnston et al., 2016). Although 
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students who attend college are less likely to use cannabis prior to graduating from high school 
than their peers who do not attend college, the prevalence of cannabis use among young adults 
attending college is increasing at a higher rate than the prevalence of cannabis use among their 
counterparts who do not attend college (Johnston et al., 2016; White, Labouvie, & 
Papadaratsakis, 2005). Past-year cannabis use was 51% higher among college students than their 
same-age, non-college peers in 2015, 41% in 2014, and 31% in 2013 (Johnston et al., 2016). The 
National Survey Results on Drug Use from 1975-2015 reported that perceived availability of 
cannabis is higher among 12th graders through 27- to 30-year-olds versus 35- to 55-year-olds 
(81-87% versus 69-80%), which could play a role in why cannabis is currently the most 
commonly used illicit drug among college students (Blavos et al., 2017; Johnston et al., 2016; 
Suerken et al., 2014). 
Trends in cannabis use among college students mirror trends in the general population. 
The National Survey Results on Drug Use from 1975-2015 also found that cannabis use is higher 
among college males than females (40% versus 33%) and college males are three times as likely 
to report daily cannabis use compared to females (8.7% versus 3.9%) (Johnston et al., 2016). 
Among a random sample of first-year college students from two large public universities, 65.1% 
of students who reported cannabis use in the past month also reported alcohol use during that 
time period and 23.2% of males and 8.5% of females reported using both substances on the same 
day (Whitehill, Rivara, & Moreno, 2014). Concurrent use of cannabis and alcohol is one of the 
most common forms of polydrug mix among college students and one of the best predictors of 
both substances use is peer use (Windle, Haardorfer, Lloyd, Foster, & Berg, 2017). Since 
cannabis use phenotypes are often comorbid with other substance use phenotypes (e.g., nicotine 
and alcohol; i.e., polysubstance use) those are key variables to control for in future cannabis use 
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research. The strong association between peer use and cannabis use among college students may 
be due to greater personal autonomy, different living circumstances, a new and larger 
socialization network, increasing legalization in some states, and perceived easier access to 
substances (Windle & Zucker, 2010). Thus, it is important to examine potentially modifiable 
variables (i.e., other substance use, peer substance use, social network, coping strategies) 
associated with increased risk for cannabis use. College may be a period of increased risk for 
exposure to problematic cannabis use, but it is also a time of increased risk to trauma exposure, 
which both can contribute to the development of cannabis use phenotypes among college 
students. 
Summary: Correlates of Cannabis Use Phenotypes 
 In summary, cannabis is the most commonly used illicit drug (Johnston et al., 2006; 
Rouse et al., 2002). Those in the general population between the ages of 18- and 29-years old 
have been shown to be at high risk for this type of substance misuse, with usage rates of 21% 
(Hasin et al., 2015). Race and ethnicity, sex, and year-in-school have often been cited as 
covariates in cannabis use and CUD literature. However, there continues to be a lack of 
consensus on rates and motivations based on these demographics. Thus, it is important to 
consider age-, sex-, racial-, and ethnic-specific patterns of cannabis use and CUD in future 
cannabis research in order to give clarity to these discrepancies. It is also important to control for 
other substance use phenotypes (e.g., nicotine and alcohol) that are commonly used with 
cannabis in further cannabis research. In addition to age, sex, race, and ethnicity as established 
risk factors for cannabis use, there are also associations between trauma-related factors (i.e., 
trauma exposure and PTSD) and cannabis phenotypes (i.e., cannabis use and CUD). 
Prevalence and Correlates of Trauma Exposure and PTSD 
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According to the American Psychiatric Association’s (APA) DSM-5 (2013), a traumatic 
event is defined as “exposure to actual or threatened death, serious injury, or sexual violence,” 
which includes, but is not limited to, sexual abuse, physical abuse, domestic violence, 
community and school violence, suicides, and other traumatic losses. Trauma exposure is 
universally common among all populations. Twenty-four countries across six continents assessed 
trauma exposure with a list of 29 types of traumatic events among a sample of 68,894 adults and 
over 70% of respondents reported exposure to at least one traumatic event and 30.5% reported 
exposure to four or more traumatic events (Benjet et al., 2016). The U.S. had the third highest 
prevalence of trauma exposure (82.7%) of all countries included in the study (Benjet et al., 
2016). Consistently, in a representative sample of U.S. adults, most respondents (89.7%) 
reported exposure to at least one DSM-5 PTSD Criterion A traumatic event (Kilpatrick et al., 
2013). 
Sociodemographic predictors of trauma exposure include sex, race, ethnicity, and age. 
Women are more likely than men to be exposed to intimate partner or sexual violence, but men 
are more likely than women to experience all other types of traumatic events such as 
interpersonal violence (i.e., human-perpetrated violence) or being mugged with a weapon (Benjet 
et al., 2016). Similar to sex, racial/ethnic group differences in risk for exposure to traumatic 
events has been shown to vary by type of event. Based on a large, representative sample of U.S. 
adults, Roberts and colleagues (2011) found that Caucasian individuals were more likely than 
other racial/ethnic groups to be exposed to any traumatic event, but African-American and 
Hispanic individuals were more likely than Caucasian individuals to be exposed to childhood 
trauma and witnessing domestic violence, and African-American, Hispanic, and Asian-American 
individuals had a higher risk of war-related trauma exposure than Caucasian individuals. 
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Regarding cohort effects, individuals below the age of 65-years old are more likely to experience 
interpersonal violence, sexual violence, accidents, injuries, unexpected death of a loved one, and 
being mugged, but this increased risk decreases with age (Benjet et al., 2016). Being a college 
student was specifically associated with an increased risk for most types of trauma exposure 
unrelated to collective violence, having a life-threatening illness, and having a child with a 
serious illness suggesting something unique about the developmental period of college (Benjet et 
al., 2016). 
Exposure to a traumatic event is a criterion for a diagnosis of PTSD. PTSD is a disorder 
characterized by the following primary symptom areas: exposure to a traumatic event, intrusion 
or re-experiencing (i.e., recurrent recollections of the event), fear or avoidance behaviors, 
changes in mood and cognition (i.e., negative alterations in emotions or thoughts), arousal and 
hyper-reactivity (i.e., agitation, state of constant wakefulness and alertness) (American 
Psychiatric Association, 2013). PTSD is only diagnosed when the symptoms last more than a 
month, seriously affect an individual’s ability to function, and are not due to substance use, 
medical illness, or anything except the event itself. According to a systematic review of 35 
studies investigating PTSD prevalence and trajectories in trauma exposed populations, an 
estimated 25.4% of those exposed to a traumatic event go on to meet DSM-5 criteria for PTSD 
one month post-trauma (Santiago et al., 2013). PTSD prevalence rates decrease to 18.8% three 
months post-trauma and remain steady at twelve months post-trauma (17.7%) (Santiago et al., 
2013). The National Comorbidity Survey – Replication (NCS-R) estimated the prevalence rate of 
lifetime PTSD based on the DSM-IV diagnostic criteria to be about 6.8% among a nationally 
representative sample of U.S. adults (Kessler, Berglund, et al., 2005). The National 
Epidemiologic Survey on Alcohol and Related Conditions documented similar estimates of 
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DSM-IV lifetime PTSD (6.4%) among a representative sample of U.S. adults (Pietrzak, 
Goldstein, Southwick, & Grant, 2011). PTSD in DSM-5 differs significantly from DSM-IV. The 
stressor criterion is more explicit with regard to what classifies as a traumatic event. Also, the 
subjective reaction of needing to feel intense fear, helplessness, or horror during the traumatic 
event has been removed. The three major symptom clusters in DSM-IV (e.g., reexperiencing, 
avoidance/numbing, and arousal) are now four symptom clusters in DSM-5. The DSM-IV 
avoidance/numbing cluster is divided into two distinct clusters in the DSM-5: avoidance and 
negative alterations in cognitions and mood. Negative alterations in cognitions and mood 
retained most of the DSM-IV numbing symptoms, but also includes new symptoms, such as 
persistent negative emotional states. Lastly, alterations in arousal and hyper-reactivity retains 
most of the DSM-IV arousal symptoms, but also includes irritable or aggressive behavior and 
reckless or self-destructive behavior. Despite these major revisions to what qualifies for a 
diagnosis of PTSD, the prevalence rates remain relatively similar across the DSM-IV and DSM-
5. More recently, results from the National Stressful Events Survey documented similar 
estimates of DSM-IV lifetime PTSD (10.6%) and DSM-5 lifetime PTSD (9.4%), which sampled 
a demographically and geographically representative group of U.S. adults (Kilpatrick et al., 
2013). 
Many factors play a part in whether an individual will develop PTSD after experiencing a 
traumatic event. In a meta-analysis across 77 studies examining risk factors for PTSD in trauma-
exposed adults, Brewin and colleagues (2000) found pre-trauma (e.g., sex, race, low 
socioeconomic status), peri-trauma (e.g., trauma severity), and post-trauma (e.g., low social 
support, subsequent life stress) factors that were associated with a greater likelihood of 
developing PTSD. Although women are less likely than men to be exposed to a traumatic event, 
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women have a two to three times higher risk of developing PTSD compared to men (Olff, 2017). 
The lifetime prevalence of PTSD ranges from 10–12% in women and 5–6% in men (Olff, 2017). 
Racial/ethnic differences in PTSD have been investigated and Roberts and colleagues (2011) 
found that the lifetime prevalence of PTSD was highest among African-American individuals 
(8.7%), intermediate among Caucasian and Hispanic individuals (7.4% and 7.0%), and lowest 
among Asian-American Individuals (4.0%). Regarding age as a pre-trauma vulnerability factor 
for PTSD, the NCS-R found that individuals aged 18- to 29-years old had the highest odds of a 
lifetime risk for PTSD compared to 30- to 44-year olds and 45- to 59-year olds (Kessler, 
Berglund, et al., 2005). College students are in that critical age range for an increased risk for 
PTSD and constitute a sizeable cohort of the U.S. population. These pre-trauma characteristic 
differences are attributed to a variety of cultural, socioeconomic, and cohort phenomena.  
Psychosocial factors, in addition to demographic variables, contribute to PTSD risk. A 
meta-analysis across 68 studies examining predictors of PTSD and symptoms in adults found 
that risk factors for developing PTSD besides low social support had a stronger effect if the 
index trauma was noncombat interpersonal violence (Ozer, Best, Lipsey, & Weiss, 2003). 
Similarly, Frans and colleagues (2005) examined the lifetime prevalence of traumatic 
experiences and PTSD and found that the highest risk for developing PTSD was associated with 
IPT (i.e., sexual and physical assault), robbery, and multiple trauma experiences. Recently, 
Kilpatrick and colleagues (2013) also found that the prevalence of PTSD was highest among 
victims of IPT and combat. Consistent evidence supports IPT being more likely to lead to PTSD 
than accidental trauma. Ozer and colleagues (2003) also found that low perceived social support 
following a traumatic event was associated with greater development of PTSD. According to 
Brewin and colleagues (2000), lack of social support and more subsequent life stress were two of 
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the three peri- and post-trauma factors that convey the strongest risk of PTSD. Given the 
knowledge on pre- peri- and post-trauma risk factors, it is important to investigate trauma 
exposure and PTSD in high risk subpopulations (i.e., college students) in order to better 
understand the negative effects both acutely and in the longer-term. 
Trauma Exposure and PTSD among College Students. Trauma exposure is common 
among young adults, and exposure in young adults in a college environment is of particular 
concern. Estimates of the prevalence of exposure to traumatic events among college students 
have been as high as 84% (Scarpa et al., 2002; Vrana & Lauterbach, 1994). More recently, 
preliminary results from Spit for Science, an ongoing representative study of college students 
used for the current study, found a similarly high prevalence rate of exposure to traumatic events 
(82%) (Overstreet, Berenz, Kendler, Dick, & Amstadter, 2017). Additionally, 39% of college 
students reported a lifetime prevalence of experiencing an interpersonal traumatic event, which is 
more likely to lead to PTSD than accidental trauma. Using a more conservative definition of a 
traumatic event, Read and colleagues (2011) found the prevalence of DSM-IV criterion A trauma 
exposure among newly matriculated college students to be slightly lower (66%) than exposure to 
traumatic events. More specifically, 23% reported exposure to one traumatic event, 20% reported 
two events, and 25% reported three or more events. In a sample of college students, 67% of 
participants reported experiencing at least one traumatic event based on DSM-5 PTSD’s criteria 
and 59% of participants met criteria for DSM-5 PTSD (Elhai et al., 2012). Notably, rates of 
occurrence of trauma exposure have been shown to peak sharply between ages 16- to 20-years 
old, which overlaps with the ages of the average college population (Breslau et al., 1998). 
Therefore, college students are at an increased risk for trauma exposure and PTSD than the 
general population across the lifespan. 
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Lifetime estimates of DSM-IV and DSM-5 PTSD in the general population are as high as 
10% (Kilpatrick et al., 2013). Similar to how college students have an increased risk for trauma 
exposure compared to other age groups, they also have an increased risk for developing PTSD. A 
limited number of recent studies have examined the prevalence of trauma exposure and PTSD in 
college students, estimating rates of PTSD to be in the range of 8%–15% (Frazier et al., 2009; 
Netto et al., 2013; Read et al., 2011; Smyth, Hockemeyer, Heron, Wonderlich, & Pennebaker, 
2008; Watson & Haynes, 2007). Studies suggest that college students are at an increased risk for 
developing PTSD, but these studies have been limited by a focus on PTSD in only women 
(Watson & Haynes, 2007), small sample sizes (Smyth et al., 2008), or a cross-sectional study 
design (Frazier et al., 2009; Netto et al., 2013), and so onset or causality cannot be determined. 
PTSD and SUD Comorbidity 
Although trauma is most closely associated with PTSD, trauma is a transdiagnostic risk 
factor for a variety of conditions, including SUDs. PTSD and SUD comorbidity is common with 
estimated prevalence rates of PTSD among individuals with SUD ranging from 25% to 45% or 
almost three to five times more likely than in the general population (Dore, Mills, Murray, 
Teesson, & Farrugia, 2012; Dragan & Lis-Turlejska, 2007; Gielen, Havermans, Tekelenburg, & 
Jansen, 2012; Reynolds, Hinchliffe, Asamoah, & Kouimtsidis, 2011). Individuals with comorbid 
PTSD and SUD have an increased risk for more severe symptoms (Peirce, Kindbom, Waesche, 
Yuscavage, & Brooner, 2008), other psychiatric problems (i.e., depression, anxiety) (Pietrzak et 
al., 2011), suicidality (Pietrzak et al., 2011), morbidity and mortality (Bohnert et al., 2013; 
Possemato, Wade, Andersen, & Ouimette, 2010), unemployment (Najavits & Hien, 2013), and 
social impairment (Najavits & Hien, 2013). Additionally, the comorbidity is economically 
burdensome on the healthcare system, as it results in increased service use (Bowe & Rosenheck, 
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2015) and worse treatment prognosis (Mills, Lynskey, Teesson, Ross, & Darke, 2005). A 
majority of comorbid PTSD and SUD studies have focused on alcohol, the most commonly co-
occurring SUD comorbid with PTSD (Debell et al., 2014), and nicotine (Fu et al., 2007). 
However, the literature is much more limited in studies on PTSD and SUD comorbidity that have 
focused on cannabis use and CUD specifically. 
Trauma Exposure, PTSD, and Cannabis Use Phenotypes 
 Although the literature on trauma, PTSD, cannabis, and CUD comorbidity is smaller than 
that of other substances, there is evidence of associations between these phenotypes found across 
multiple study designs: acute increases post-trauma (Vlahov et al., 2002), community (Buckner, 
Joiner, Schmidt, & Zvolensky, 2012), clinical (Bonn-Miller et al., 2012; Compton, Simmons, 
Weiss, & West, 2011), and epidemiologic (Agosti, Nunes, & Levin, 2002; Kilpatrick et al., 
2000). 
In a study examining the acute effects of the September 11, 2001 terrorist attacks among 
Manhattan, New York residents, Vlahov and colleagues (2002) saw a 29% increase in substance 
use (i.e., alcohol, nicotine, cannabis) 5-8 weeks after the attack. Specifically, 3.2% of local 
residents reported an increase in cannabis use during the acute post-disaster period (Vlahov et al., 
2002). Additionally, an increase in cannabis use was associated with an increased likelihood of 
developing PTSD compared to no use or no increase (36.0% versus 6.6%) (Vlahov et al., 2002). 
Results suggest that cannabis use increases after acute trauma exposure, but research in a more 
representative sample is required to investigate the relationship between trauma exposure and 
cannabis use more broadly. 
The NCS-R is one of the few epidemiologic studies that examined co-occurring trauma 
and substance use phenotypes (Kessler, Chiu, Demler, Merikangas, & Walters, 2005). However, 
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one limitation of the NCS-R is that the results were not specific to cannabis use phenotypes, and 
were instead focused on substance use broadly in relation to PTSD. This study found that a 
diagnosis of DSM-IV PTSD was significantly related to a diagnosis of a DSM-IV substance use 
disorder (e.g., alcohol or drug) (Kessler, Chiu, et al., 2005). In another epidemiologic study, 
Kevorkian and colleagues (2015) examined the relationship between trauma exposure, PTSD, 
and cannabis use phenotypes and found that a lifetime history trauma exposure was associated 
with a 1.2 increased likelihood of lifetime cannabis use. Additionally, among those endorsing 
lifetime trauma exposure and cannabis use lifetime PTSD was associated with a 1.2 increased 
likelihood of CUD. In a large representative sample of U.S. adults who reported data on current 
and lifetime psychiatric diagnoses and answered questions related to lifetime and current 
cannabis use from the NCS-R, Cougle and colleagues (2011) found that lifetime PTSD was 
associated with greater odds of lifetime, past-year, and daily cannabis use above and beyond 
demographic and psychiatric correlates, such as sex, ethnicity, age, and trauma load. 
Specifically, individuals with a lifetime and past-year PTSD were 3.3 and 3.4 times more likely 
to have lifetime cannabis use, respectively (Cougle et al., 2011). Interestingly, Cougle and 
colleagues (2011) also found that 50.4% of individuals with both a lifetime PTSD diagnosis and 
lifetime cannabis use reported that their PTSD onset preceded or occurred at the same time as the 
first time they used cannabis. These results suggest a potentially causal relationship between 
trauma and cannabis phenotypes. However, this relationship has primarily been studied in cross-
sectional epidemiological studies. Given the greater than chance relationship between post-
trauma psychopathology and cannabis use phenotypes, smaller clinical samples have been 
studied to examine the co-occurrence more closely. 
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In a sample of veterans receiving care in the Veterans Affairs Health Care System, Bonn-
Miller and colleagues (2012) found that the prevalence of CUD diagnoses have increased from 
0.66% to 1.05% between 2002 and 2009, which is more than a 50% increase over 7 years. 
Additionally, the prevalence of patients with a CUD diagnosis but no other illicit SUD diagnosis 
increased from 0.27% to 0.58% between 2002 and 2009, which is more than a 115.41% increase 
during the same time period. Of those individuals with a CUD, but no other illicit SUD 
diagnosis, 23%, 27%, and 29% also met diagnostic criteria for PTSD in 2002, 2008, and 2009, 
respectively. Results indicate that the rate of PTSD and CUD comorbidity is increasing. It 
remains unclear if PTSD comorbidity among individuals with CUD are causes, consequences, or 
correlates of CUD, but further investigation of the association is necessary. 
Trauma exposure and PTSD are highly related to substance use phenotypes (Jacobsen, 
Southwick, & Kosten, 2001), and cannabis use phenotypes are increasing among individuals 
with PTSD (Bonn-Miller et al., 2012; Cougle et al., 2011). Given the associations between PTSD 
and cannabis use phenotypes, there have been numerous theories that have attempted to address 
the high rates of co-occurrence. Co-occurrence of these two conditions may begin when a person 
attempts to self-medicate their PTSD symptoms, or cannabis use could lead to PTSD if the 
person experiences trauma caused by their cannabis use, like a car accident or physical violence 
(Chilcoat & Breslau, 1998). Although cannabis is being considered as a potential mental health 
treatment to ease distressing symptoms in individuals with PTSD, the drug may enhance some 
symptoms associated with PTSD, making the condition worse (Shishko, Oliveira, Moore, & 
Almeida, 2018). 
The Self-Medication Hypothesis 
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The self-medication hypothesis is the most prominent and widely accepted phenotypic 
model of comorbidity that is thought to explain the development of comorbid PTSD and SUD 
(Khantzian, 1985). The self-medication hypothesis purports that individuals with trauma 
exposure and/or PTSD engage in substance use in an effort to alleviate negative symptoms of the 
disorder and consequently develop a SUD (i.e., PTSD to SUD). Longitudinal research has found 
that PTSD symptoms often have an earlier onset than SUD symptoms (Bremner, Southwick, 
Darnell, & Charney, 1996), lending support to the purported order of onset of the self-medication 
hypothesis. Another prominent example of the dynamic relationship between PTSD and SUD 
was found over a 26-week period where increases in PTSD symptoms were positively associated 
with increases in SUD symptoms (Ouimette, Read, Wade, & Tirone, 2010). Ouimette and 
colleagues’ (2010) research suggests that individuals’ substance use symptoms are tied to their 
PTSD symptoms and that they could be showing signs of using substances in response to their 
increase in distressing PTSD symptoms. A majority of the PTSD and SUD studies that have 
attempted to test the tenants of the self-medication hypothesis have been conducted on drug use 
broadly (Reed, Anthony, & Breslau, 2007), alcohol (Breslau, Davis, & Schultz, 2003; Jacobsen 
et al., 2001), nicotine (Breslau et al., 2003; Cook, Jakupcak, Rosenheck, Fontana, & McFall, 
2009), or cocaine (Jacobsen et al., 2001), but fewer studies have examined the relationship 
between PTSD and cannabis use phenotypes. 
Those exposed to trauma are at a higher risk of using cannabis than individuals without a 
history of exposure to trauma (Kevorkian et al., 2015). Additionally, individuals with PTSD are 
at an increased risk for CUD (Cornelius et al., 2010). Cornelius and colleagues (2010) found that 
the average age of onset of PTSD was 15.4 +/- 5.6 years and the average age of onset of CUD 
was 16.7 +/- 2.3 years among trauma exposed adolescents. Cornelius and colleagues’ (2010) 
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results suggest that PTSD contributes to the etiology of CUD. Further supporting the self-
medication hypothesis for PTSD and CUD, individuals report using cannabis to regulate 
negative emotions, or help cope with intrusive PTSD symptoms (Bonn-Miller, Vujanovic, 
Boden, & Gross, 2011). Research suggests that individuals could be using cannabis to self-
medicate their PTSD symptoms, but more research is still needed to provide a more 
comprehensive evaluation of the unique associations between trauma exposure, PTSD, and 
cannabis use phenotypes.      
Not all studies have results that are consistent with the self-medication hypothesis in 
relation to PTSD and SUD. Breslau and colleagues (2003) did not find supporting evidence for 
self-medicating relationship between PTSD and alcohol use. Specifically, exposure to trauma in 
individuals with and without a diagnosis of PTSD did not predict alcohol abuse or dependence in 
a longitudinal study of young adults (Breslau et al., 2003). In a study examining the relationship 
between specific PTSD symptom clusters and substance use, Tull and colleagues (2010) found 
contradicting evidence against the self-medication hypothesis. Specifically, no evidence was 
found for a specific relationship between any of the PTSD symptom clusters and cocaine or 
alcohol (Jakupcak et al., 2010). Although the self-medication hypothesis is the most prominent 
phenotypic model of comorbid PTSD and SUD, it is possible for the relationship to be in the 
opposite direction. 
The High-Risk and Susceptibility Hypotheses 
The high-risk and susceptibility hypotheses are explanations for how comorbid PTSD 
and SUD develop that are based on the opposite causal direction for the relationship compared to 
the self-medication hypothesis (i.e., SUD to PTSD). The high-risk hypothesis states substance 
use behaviors are assumed to increase an individual’s risk of exposure to potentially traumatic 
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events and consequentially increases their risk of developing PTSD. Substance use may increase 
risk for exposure to a traumatic event by placing individuals in high-risk situations or by 
impairing recognition of danger cues in the environment (Davis, Stoner, Norris, George, & 
Masters, 2009; Windle, 1994). The susceptibility hypothesis states that substance use increases 
the likelihood of developing PTSD after being exposed to a traumatic event (Chilcoat & Breslau, 
1998). Individuals who use substances may be less able to manage peri- or post-trauma negative 
emotions because the substance use is likely to interfere with their ability to effectively manage 
increased anxiety and arousal levels or be a method of avoidance and lack of processing (Kaysen 
et al., 2011; Stewart, Pihl, Conrod, & Dongier, 1998). For example, individuals with a SUD were 
more likely to meet criteria for PTSD than individuals without a SUD following the Oklahoma 
City bombing (North et al., 1999). More recently, individuals with a history of problematic 
alcohol use were more likely to have more severe PTSD symptoms following an assault 
compared to those without a history of problematic alcohol use (Kaysen et al., 2006). Research 
has shown that age of onset of substance abuse precedes PTSD in cocaine abusing individuals 
and that the trauma is likely to be associated with the procurement and use of the drug opposed 
to childhood trauma (Brady, Dansky, Sonne, & Saladin, 1998). In a study investigating patients 
with SUD and the association with development of PTSD, cannabis use was the third most 
commonly reported drug of concern with 36% of the total sample reporting problematic use and 
40.9% of those with co-occurring PTSD reported cannabis as their principal drug of concern 
(Dore et al., 2012). A majority of the supporting studies are cross-sectional and focus on other 
substances (i.e., alcohol, cocaine) besides cannabis, which limits the generalizability of their 
findings, and thus, longitudinal studies are needed for examining the natural course of 
associations between trauma and cannabis phenotypes.  
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Shared Risk Model 
  Research also suggests that the comorbidity of PTSD and CUD may represent a shared 
vulnerability. The shared risk model hypothesizes that individuals with greater common liability 
for PTSD and CUD are more likely to develop both disorders (Krueger & Markon, 2006). Both 
PTSD and SUDs are genetically influenced. Lyons and colleagues (1993) found that heritability 
estimates ranged from 35% to 47% for combat exposure among a large sample of Vietnam male-
twin veterans. In civilian twin study, Stein and colleagues (2002) also found modest heritability 
for IPT (e.g., robbery, sexual assault), whereas exposure to accidental trauma (e.g., motor vehicle 
accident, natural disaster) was best explained by environmental influences. Beyond genetic 
influences on trauma exposure itself, PTSD is also moderately heritable with estimates ranging 
from 30% (Stein et al., 2002) to 72% (Sartor et al., 2011) for PTSD. Cannabis use phenotypes 
are also moderately influenced by genetic factors (31% for cannabis use; (Ystrom, Reichborn-
Kjennerud, Neale, & Kendler, 2014), and range from 45-79% for CUD (Agrawal & Lynskey, 
2006; Ystrom et al., 2014). Beyond the individual genetic influences on each phenotype, twin 
studies also suggest that some of the genes that account for risk may overlap. Wolf and 
colleagues (2010) examined the factor structure of PTSD and SUDs in a large study of over 
3,000 twin pairs and found that common genetic liability exists between PTSD and SUDs. Xian 
and colleagues (2000) also investigated whether and to what degree genetic and environmental 
contributions overlap among PTSD, alcohol use disorders (AUD) and SUDs in a large study of 
over 3,000 veteran twin pairs and found that about 15% of genetic risk for PTSD was shared 
among AUDs and SUDs. Although not specific to cannabis use phenotypes, Xian and 
colleague’s (2000) results suggest that PTSD and CUD share common risk. This shared genetic 
influence may in part account for PTSD and CUD comorbidity. However, further research is 
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necessary in order to understand shared risk factors for trauma and cannabis phenotypes, 
specifically. 
Summary 
Cannabis use and its associations marks an interesting area of research as legal 
restrictions become less stringent (Hall, 1994, 2006). Based on cross-sectional and longitudinal 
evidence in other populations, trauma and PTSD seem to be well established as risk factors at 
least for initiation of cannabis use and the use of other illicit substances (i.e., alcohol, nicotine, 
cocaine). Most PTSD and SUD comorbidity research has been done on other drugs warranting 
more research focused specifically on PTSD and CUD comorbidity. Given the vast public health 
implication of CUD and PTSD, there is a clinical and research imperative for a better 
understanding of the etiology of these co-occurring conditions. Given the inconsistencies within 
the literature, continued examination is necessary to clarify our understanding of cannabis use 
and its correlates. The majority of research on PTSD and CUD among young adults has been 
limited by cross-sectional study design that do not allow a detailed analysis of the dynamic 
relationship between trauma exposure, PTSD, cannabis use, and CUD. Given the limitations of 
cross-sectional studies with regard to testing the potential causal relations (i.e., self-medication 
and high-risk hypotheses) between these phenotypes, longitudinal studies are needed. To date, no 
longitudinal studies have simultaneously examined the role of trauma exposure and PTSD for 
using cannabis and for developing CUD in young adults and vice versa. This study addresses this 
gap in the literature by examining the onset and testing the directional relationship of trauma 
exposure and cannabis use phenotypes. 
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Current Study 
The current study aimed to 1) determine the prevalence and baseline correlates of lifetime 
any (i.e., yes/no), experimental (i.e., use 1-5 times), and problematic (i.e., use ≥ 6 times) 
cannabis use and lifetime IPT exposure in relation to each other among college students prior to 
college enrollment; 2) to examine the self-medication and high-risk hypotheses by investigating 
the bidirectional relationship between IPT exposure and cannabis use among college students 
over time; 3) further investigate the self-medication and high-risk hypotheses by examining 
probable PTSD as a potential mediator in the relationship between IPT exposure and cannabis 
use as well as examining IPT exposure as a potential mediator in the relationship between 
cannabis use and probable PTSD. It was hypothesized that: (1a) there will be significant 
differences in lifetime cannabis use between sexes (i.e., men will be more likely to use compared 
to women) and racial groups, (i.e., racial minorities will be more likely to use compared to White 
individuals); and (1b) there will be significant differences in lifetime IPT exposure between 
sexes (i.e., women will be more likely to experience IPT than men) and racial groups (i.e., racial 
minorities will be more likely to experience IPT than White individuals); (2a) lifetime IPT 
exposure assessed at year 1 Fall will be positively associated with new onset cannabis use 
threshold assessed at year 1 Spring; (2b) lifetime cannabis use threshold assessed at year 1 Fall 
will be positively associated with new onset IPT exposure count assessed at year 1 Spring; (3a) 
probable PTSD assessed at year 1 Spring will mediate the relationship between IPT exposure 
count assessed at year 1 Fall and cannabis use threshold assessed at year 2 Spring; and (3b) IPT 
exposure count assessed at year 1 Spring will mediate the relationship between cannabis use 
threshold assessed at year 1 Fall and probable PTSD assessed at year 2 Spring. 
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Data will be drawn from The Spit for Science: A Virginia Commonwealth University 
Student Survey (Dick et al., 2014), a large, representative longitudinal study, to accomplish these 
aims. 
Methods 
Participants 
The current study included baseline (i.e., year 1 Fall) and follow-up (i.e., year 1 Spring 
and year 2 Spring) data from the first four cohorts of Spit for Science (N=9,889). Data from the 
parent study was collected from 2011-2014 when all incoming students aged ≥ 18 years were 
invited to participate in a university-wide research study on college behavioral health. 
Approximately 2 weeks before arriving on campus, information was mailed to all incoming 
students and (separately) to their parents. The week before Welcome Week all eligible students 
(age 18 or older) received an e-mail through their university e-mail account inviting them to 
participate in the project. Participants were representative of the broader student population 
attending Virginia Commonwealth University (VCU), in terms of both sex and race. The VCU 
Institutional Review Board (IRB) approved all study procedures and informed consent was 
obtained from all study participants. Study data were collected and managed using REDCap 
(Research Electronic Data Capture), hosted at VCU. REDCap is a secure, web-based application 
designed to support data capture for research studies, providing 1) an intuitive interface for 
validated data entry; 2) audit trails for tracking data manipulation and export procedures; 3) 
automated export procedures for seamless data downloads to statistical packages; and 4) 
procedures for importing data from external sources. Participants completed an online survey 
during the Fall of their freshman year in REDCap assessing a variety of factors including 
childhood experiences, personality, relationships, and behavior, receiving $10 and a t-shirt as 
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compensation. Detailed information concerning recruitment can be found in (Dick et al., 2014). 
Measures 
 Given the large-scale nature of the parent Spit for Science study, measures were 
abbreviated to reduce participant burden. Item response theory modeling was used to justify all 
scale modifications using data from the first wave of the study. Specifically, by investigating the 
item characteristic and information curves, items that resembled the calibrating information for 
estimating subjects’ location on the latent factor were removed. If an item was distinct enough 
compared with the other items included as indicators of the factor and items that optimally 
functioned on the latent continuum, then they were included in the measures. Therefore, items 
that provided good discrimination at various locations along the range of the latent factor scale 
were utilized to make test administration both practical and feasible. Unless otherwise stated, 
given the longitudinal nature of the dataset, each variable described below was calculated the 
same way for each time point. 
 Demographics. Data regarding demographics were drawn from the baseline (year 1 Fall) 
survey. These questions included self-reported sex, race, cohort, and age. For sex, men were 
coded as 0 and women were coded as 1 in order to compare men to women. For race, 3 dummy 
coded variables were created for White, Black, Asian, and Other (i.e., American Indian/Alaska 
Native, Hispanic/Latino, Native Hawaiian/Other Pacific, more than one race, unknown, and I 
choose not to answer) with White as the reference group in order to make the following 
comparisons: White versus Black, White versus Asian, and White versus Other. For cohort, 3 
dummy coded variables were created for cohorts one through four with one as the reference 
group in order to make the following comparisons: one versus two, one versus three, and one 
versus four. 
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 Cannabis Use. Lifetime use and total times used was measured using items adapted from 
the Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA) (Bucholz et al., 
1994). Recent cannabis use was assessed using items adapted from Substance Abuse and Mental 
Health Service Administration (Substance Abuse and Mental Health Service Administration, 
2013). In baseline surveys, participants were asked if they had ever used (yes/no response 
options) and, if so, how many times (free response). Use 1-5 times was classified as 
“experimental” use and use 6 or more times was classified as “problematic” use, which will be 
referred to as the “cannabis use threshold” variable. During their follow-up Spring survey the 
first year, participants were asked the same questions about use “since VCU,” roughly 
corresponding to past 6 months use. In all other Spring follow-up surveys, participants were 
asked the same questions about past 12-months use and number of times used. 
 Interpersonal Trauma Exposure (IPT). Traumatic event (TE) exposure was assessed at 
baseline (e.g., year 1 Fall) using an abbreviated version of the Life Events Checklist (Gray, Litz, 
Hsu, & Lombardo, 2004). Participants were asked to report on the occurrence of five different 
stressful events: natural disasters, physical assaults, sexual assaults, other unwanted or 
uncomfortable sexual experiences, and transportation accidents. Response options were “yes” or 
“no” to items regarding whether each stressful event occurred “before the past 12 months”, 
“during the past 12 months”, or “never happened to me”. If a participant endorsed that the event 
occurred either “before the past 12 months”, or “during the past 12 months”, it was considered a 
positive endorsement of TE exposure prior to college. If a participant did not endorse any of the 
aforementioned options or reported that the events “never happened to me”, it was considered a 
negative endorsement of TE history. Categories were further clustered by interpersonal TEs (i.e., 
physical assaults, sexual assaults, other unwanted or uncomfortable sexual experiences). The 
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clustering created two IPT variables, which were utilized in this study: An IPT endorsement 
variable (i.e., yes/no) and an IPT count variable ranging from 0-3 for each type of IPT event. The 
same items were utilized during year 1 Spring and yearly Spring follow-ups, however, the 
timeframe of reference was altered to appropriately capture events occurring “since VCU” and 
“in the past 12 months”, respectively. 
Probable PTSD. If a participant endorsed a TE on the Life Events Checklist (Gray et al., 
2004) or the single item derived from stressful events measure (Kendler, Karkowski, & Prescott, 
1999) they were prompted to respond to four PTSD screener items (four items; α = .93). The 
PTSD screener items were derived from the Primary Care PTSD Screen (PC-PTSD), previously 
used in screening PTSD symptoms in primary care settings (Prins et al., 2016). The four items 
ask whether the participant has ever experienced: nightmares, attempts to avoid thoughts or 
reminders of the potentially traumatic experience, hypervigilance, and feelings of detachment. 
The total symptom count (ranging from 0-4) was used as the primary PTSD variable in analyses, 
and based on standardized scoring for this measure; endorsement of three or more items was 
used as indication of a positive lifetime history of probable PTSD. Cohort 4 is the only cohort 
that received the four-item measure of probable PTSD. Cohorts 1 through 3 received a version of 
probable PTSD assessment where all four items were asked in one question and endorsement of 
any item (e.g., nightmares, attempts to avoid thoughts or reminders of the potentially traumatic 
experience, hypervigilance, and feelings of detachment) was used as indication of a positive 
lifetime history of probable PTSD. Assessments for cohorts one through four were combined to 
create an endorsement of probable PTSD variable (i.e., yes/no), where a score greater than 0 
classified as probable PTSD. Response options were coded as 0 and 1, where 0 was indicative of 
no probable PTSD and 1 was indicative of probable PTSD. 
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Alcohol Use Frequency. Average frequency of alcohol use during the past year was 
assessed using the frequency items from the Alcohol Use Disorder Identification Test (AUDIT; 
(Bohn, Babor, & Kranzler, 1995). Response options for frequency (“How often do you have a 
drink containing alcohol?”) were “never”, “monthly or less”, “2 to 4 times a month”, “2 to 3 
times a week”, or “4 or more times a week.” Response options were coded from 0 to 4, where 
higher responses were indicative of more frequent alcohol use. 
Nicotine Use Frequency. Nicotine use was assessed across 4 categories: cigarettes, 
cigars, smokeless tobacco, and hookah. Lifetime use and total quantity consumed was assessed 
using items adapted from the SSAGA (Bucholz et al., 1994). Recent (past 30 days) frequency of 
use was measured using items adapted from SAMSHA (Substance Abuse and Mental Health 
Service Administration, 2013). For each nicotine category, participants were asked how 
frequently they used the product in the last 30 days. Answer options were “I did not use,” “Once 
or twice,” “A few days (3 to 4 days a month),” “A couple of days a week (5 to 11 days a 
month),” “3 times a week (12 to 14 days a month),” “most days of the week (15 to 25 days a 
month),” and “daily or almost daily (26 to 30 days a month).” Response options specifically for 
cigarette use were coded from 0 to 6, where higher responses were indicative of more frequent 
nicotine use. 
Data Analytic Plan 
 
Multiple Imputation.  Missing data was imputed using the R package “missForest” 
(Stekhoven & Buhlmann, 2012). A non-parametric multiple imputation method was applied to 
estimate missing data in five binary variables of cannabis use from year 1 Fall, year 1 Spring, 
and year 2 Spring. Eight iterations of the imputation process were performed until reaching an 
optimal stopping point. The imputation was based on six binary (3 cannabis, 3 alcohol) and nine 
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categorical (3 cannabis, 3 nicotine, and 3 alcohol) variables from years 1 to 2. The overall 
estimate of imputation error was 0.1459 based on the proportion of falsely classified (PFC) 
entries, with the PFC of the six binary variables of cannabis use ranging between 0.00 and 
0.0002. It is expected that good performance results of imputation with “missForest” will give a 
value close to 0, in contrast with inadequate results returning values close to 1 (Stekhoven & 
Buhlmann, 2012). The imputed dataset was used for all analyses. 
Overview of Data Analytic Plan. Detailed descriptions of the data analytic plan are 
presented prior to the results of each aim. In brief, Aim 1 utilized a multinomial logistic 
regression framework in order to test predictors of (1a) experimental and problematic cannabis 
use and (1b) lifetime IPT exposure. Aim 2 and Aim 3 utilized cross-lagged path analyses in order 
to test the relations among cannabis use, IPT exposure, and probable PTSD. Additionally, Aim 
3’s path analyses utilized a mediational framework.  
Determination of Statistical Significance. Due to the large number of participants (n = 
9889) and research suggesting that p-values become less meaningful with very large samples 
(Sullivan & Feinn, 2012), a more stringent significance level (i.e., p < .001) was set to determine 
statistical significance. 
Aim 1 Analyses. Analyses for Aim 1 examined cross-sectional predictors of (1a) lifetime 
experimental and problematic cannabis use and (1b) lifetime IPT exposure assessed at the 
beginning of college at year 1 Fall. Specifically, two sets of multinomial logistic regressions 
were employed using a model building approach in order to test the hypotheses that (1a) lifetime 
IPT exposure is a significant predictor of lifetime experimental and problematic cannabis use 
above and beyond covariates and (1b) lifetime cannabis use is a significant predictor of lifetime 
IPT exposure above and beyond covariates. Covariates included sex, race, cohort, lifetime IPT 
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exposure (in the model predicting experimental and problematic cannabis use), lifetime cannabis 
use (in the model predicting IPT exposure), alcohol use frequency, and nicotine use frequency. 
Data were analyzed using SPSS Version 24 (IBM Corporation, 2016). 
 
Results 
Aim 1 Participant Characteristics 
 Descriptive statistics are presented in Table 1. The majority of participants in the present 
sample reported that they were White (n = 4959, 50.1%) and female (n = 6083, 61.5%). 
Participation across all four cohorts was about equal. Prevalence of lifetime IPT and probable 
PTSD upon college entry was 35.9% (n = 3549) and 32.2% (n=3186), respectively. 
  
Table 1. Demographic and Clinical Characteristics of Substance Users and Non-Users at Year 1 Fall 
 
 Full 
Sample 
N = 9889 
No 
Cannabis, 
Alcohol, or 
Nicotine 
N = 1948 
(19.7%)* 
Cannabis 
Only 
N = 276 
(2.8%)* 
Alcohol 
Only 
N = 2290 
(23.2%)* 
Nicotine 
Only 
N = 213 
(2.2%)* 
Cannabis 
and 
Alcohol 
N = 1811 
(18.3%)* 
Cannabis 
and 
Nicotine 
N = 467 
(4.7%)* 
Alcohol 
and 
Nicotine 
N = 772 
(7.8%)* 
Cannabis, 
Alcohol, 
and 
Nicotine 
N = 2112 
(21.4%)* 
Characteristic n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
Race          
White 4959 
(50.1%) 
677 
(34.8%) 
153 
(55.4%) 
1065 
(46.5%) 
110 
(51.6%) 
931 
(51.4%) 
118 
(25.3%) 
483 
(62.6%) 
1422 
(67.3%) 
Black 1900 
(19.2%) 
527 
(27.1%) 
39 
(14.1%) 
486 
(21.2%) 
32 
(15.0%) 
362 
(20.0%) 
177 
(37.9%) 
70 
(9.1%) 
207 
(9.8%) 
Asian 1640 
(16.6%) 
501 
(25.7%) 
45 
(16.3%) 
462 
(20.2%) 
65 
(30.5%) 
262 
(14.5%) 
7 
(1.5%) 
143 
(18.5%) 
155 
(7.3%) 
Other 1390 
(14.1%) 
243 
(12.5%) 
39 
(14.1%) 
277 
(12.1%) 
6 
(2.8%) 
256 
(14.1%) 
165 
(35.3%) 
76 
(9.8%) 
328 
(15.5%) 
Cohort          
1 2707 
(27.4%) 
524 
(26.9%) 
106 
(38.4%) 
731 
(31.9%) 
 23 
(10.8%) 
421 
(23.2%) 
169 
(36.2%) 
196 
(25.4%) 
537 
(25.4%) 
2 2481 
(25.1%) 
560 
(28.7%) 
86 
(31.2%) 
588 
(25.7%) 
46 
(21.6%) 
417 
(23.0%) 
40 
(8.6%) 
201 
(26.0%) 
543 
(25.7%) 
3 2391 
(24.2%) 
462 
(23.7%) 
33 
(12.0%) 
505 
(22.1%) 
48 
(22.5%) 
479 
(26.4%) 
121 
(25.9%) 
210 
(27.2%) 
533 
(25.2%) 
4 2310 
(23.4%) 
402 
(20.6%) 
51 
(18.5%) 
466 
(20.3%) 
96 
(45.1%) 
494 
(27.3%) 
137 
(29.3%) 
165 
(21.4%) 
499 
(23.6%) 
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Table 1 (cont.). Demographic and Clinical Characteristics of Substance Users and Non-Users at Year 1 Fall 
Note: * = percent of full sample; IPT = Interpersonal trauma; PTSD = Posttraumatic stress disorder 
 Full 
Sample 
N = 9889 
No  
Cannabis, 
Alcohol, or 
Nicotine 
N = 1948 
(19.7%)* 
Cannabis 
Only 
N = 276 
(2.8%)* 
Alcohol 
Only 
N = 2290 
(23.2%)* 
Nicotine 
Only 
N = 213 
(2.2%)* 
Cannabis 
and 
Alcohol 
N = 1811 
(18.3%)* 
Cannabis 
and 
Nicotine 
N = 467 
(4.7%)* 
Alcohol 
and 
Nicotine 
N = 772 
(7.8%)* 
Cannabis, 
Alcohol, 
and 
Nicotine 
N = 2112 
(21.4%)* 
Characteristic n (%)/M 
(SD) 
n (%)/M 
(SD) 
n (%)/M 
(SD) 
n (%)/M 
(SD) 
n (%)/M 
(SD) 
n (%)/M 
(SD) 
n (%)/M 
(SD) 
n (%)/M 
(SD) 
n (%)/M 
(SD) 
Sex          
Men 3806 
(38.5%) 
646 
(33.2%) 
78 
(28.3%) 
986 
(43.1%) 
81 
(38.0%) 
638 
(35.2%) 
232 
(49.7%) 
243 
(31.5%) 
902 
(42.7%) 
Women 6083 
(61.5%) 
1302 
(66.8%) 
198 
(71.7%) 
1304 
(56.9%) 
132 
(62.0%) 
1173 
(64.8%) 
235 
(50.3%) 
529 
(68.5%) 
1210 
(57.3%) 
Lifetime IPT          
No 6340 
(64.1%) 
1378 
(70.7%) 
177 
(64.1%) 
1647 
(71.9%) 
129 
(60.6%) 
1145 
(63.2%) 
246 
(52.7%) 
544 
(70.5%) 
1074 
(50.9%) 
Yes 3549 
(35.9%) 
570 
(29.3%) 
99 
(35.9%) 
643 
(28.1%) 
84 
(39.4%) 
666 
(36.8%) 
221 
(47.3%) 
228 
(29.5%) 
1038 
(49.1%) 
Probable 
PTSD 
         
No 6703 
(67.8%) 
1371 
(70.4%) 
167 
(60.5%) 
1648 
(72.0%) 
150 
(70.4%) 
1157 
(63.9%) 
384 
(82.2%) 
537 
(69.6%) 
1289 
(61.0%) 
Yes 3186 
(32.2%) 
577 
(29.6%) 
109 
(39.5%) 
642 
(28.0%) 
63 
(29.6%) 
654 
(36.1%) 
83 
(17.8%) 
235 
(30.4%) 
823 
(39.0%) 
Aim 1a(i): Prevalence Estimates of Lifetime Cannabis, Nicotine, and Alcohol Use 
 Among those who reported lifetime cannabis use at year 1 Fall (n = 4498, 45.5%), a 
majority reported problematic use (i.e., use ≥ 6 times) opposed to experimental use (i.e., use 1-5 
times). Specifically, 2788 participants (28.3%) reported problematic cannabis use and 1718 
participants (17.4%) reported experimental cannabis use. Among those who reported lifetime 
cannabis, nicotine, and/or alcohol use at year 1 Fall (n = 7941, 80.3%), alcohol use only and 
polysubstance use (i.e., cannabis, nicotine, and alcohol) were the most common. Specifically, 
2290 participants (23.2%) reported only lifetime alcohol use and 2112 participants (21.4%) 
reported lifetime cannabis, alcohol, and nicotine use. 772 participants (7.8%) reported both 
lifetime alcohol and nicotine use. 467 participants (4.7%) reported both lifetime cannabis and 
nicotine use. 1811 participants (18.3%) reported both lifetime cannabis and alcohol use. 213 
participants (2.2%) reported only lifetime nicotine use. 276 participants (2.8%) reported only 
lifetime cannabis use. 1948 participants (19.7%) reported no lifetime cannabis, nicotine, or 
alcohol use. 
Aim 1a(ii): Predictors of Lifetime Experimental and Problematic Cannabis Use 
Model Building Approach: Multivariate Analyses Predicting Lifetime Problematic 
Cannabis Use 
 Multinomial logistic regression was used to examine whether demographics, lifetime IPT 
exposure, alcohol use, and nicotine use predicts lifetime experimental and problematic cannabis 
use assessed at year 1 Fall, compared to never having used. All effect sizes are reported as odds 
ratios, which can be interpreted as the relative odds (compared to the reference group of no 
lifetime use) of reporting experimental (i.e., 1-5 times) and problematic (i.e., ≥ 6 times) cannabis 
use. 
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 Model 1 (see Table 2) tested sex, race, and cohort as predictors of lifetime experimental 
and problematic cannabis use. Sex and cohort were not significant predictors of experimental 
cannabis use. Race was a significant predictor of experimental cannabis use. Specifically, White 
individuals were more likely to report experimental cannabis use compared to Black and Asian 
individuals. Sex, race, and cohort were all significant predictors of problematic cannabis use. 
Specifically, men were more likely to report problematic cannabis use compared to women; 
White individuals were more likely to report problematic cannabis use compared to Black and 
Asian individuals; and individuals from cohort three were more likely to report problematic 
cannabis use compared to individuals from cohort one.
Table 2. Model 1: Demographics Predicting Lifetime Experimental and Problematic Cannabis Use 
Model 1 
(Demographics) 
R2 Lifetime 
Cannabis Use 
Predictor β Std. 
Error 
Wald’s χ2 df p OR 95% CI 
.07 
Experimentala 
Sex (M vs. W) .03 .06 .34 1 .56 1.04 .92-1.16 
Race (W vs. B)  .36 .07 24.38 1 <.001 1.44* 1.24-1.66 
Race (W vs. A)  1.12 .09 152.52 1 <.001 3.08* 2.57-3.68 
Race (W vs. O)  .25 .09 8.44 1 .004 1.28 1.08-1.51 
Cohort (1 vs. 2)  .06 .08 .49 1 .49 1.06 .91-1.23 
Cohort (1 vs. 3)  .03 .08 .11 1 .75 1.03 .88-1.20 
Cohort (1 vs. 4)  -.24 .08 9.91 1 .002 .78 .67-.91 
Problematicb 
Sex (M vs. W) .39 .05 62.84 1 <.001 1.47* 1.34-1.62 
Race (W vs. B)  .76 .07 131.28 1 <.001 2.14* 1.88-2.44 
Race (W vs. A) 1.44 .08 332.44 1 <.001 4.20* 3.60-4.90 
Race (W vs. O)  .21 .07 8.99 1 .003 1.23 1.07-1.41 
Cohort (1 vs. 2) -.13 .07 3.59 1 .06 .88 .78-1.00 
Cohort (1 vs. 3)  -.26 .07 15.11 1 <.001 .77* .68-.88 
Cohort (1 vs. 4)  -.13 .07 3.44 1 .06 .88 .77-1.01 
Note: No lifetime cannabis use is the reference group for lifetime experimental and problematic cannabis use comparisons; * = p < 
.001; a = use 1-5 times, b = use ≥ 6 times; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O = 
Other = 1; cohort 1 = 0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1
 Model 2 (see Table 3) expanded the demographic variables in the initial model to include 
the effects of lifetime IPT exposure in the prediction of lifetime experimental and problematic 
cannabis use. For both experimental and problematic cannabis use, sex and race effects remained 
consistent with Model 1 results. Cohort was a significant predictor of experimental cannabis use. 
Specifically, individuals from cohort four were more likely to report experimental cannabis use 
compared to individuals from cohort one. Lastly, individuals with a history of IPT exposure were 
more likely to endorse both cannabis use outcomes. 
 Model 3 (see Table 4) added the effect of past 30-day nicotine and past year alcohol use 
frequency in addition to the variables described in Model 2 in the prediction of lifetime 
experimental and problematic cannabis use. Sex, race, cohort, and lifetime IPT exposure were 
consistent with Model 2 regarding experimental cannabis use. Alcohol was not a significant 
predictor of experimental cannabis use. Nicotine use was a significant predictor of experimental 
cannabis use. Specifically, individuals who reported smoking more frequently during the past 
month were more likely to report experimental cannabis use. Sex, race, cohort, and lifetime IPT 
exposure were consistent with Model 2 regarding problematic cannabis use. Nicotine and alcohol 
use were both significant predictors of problematic cannabis use. Specifically, individuals who 
reported smoking more frequently during the past month were more likely to report problematic 
cannabis use; individuals who reported more frequent alcohol consumption during the past 
month were more likely to report problematic cannabis use. 
  
Table 3. Model 2: Demographics and IPT Predicting Lifetime Experimental and Problematic Cannabis Use 
Model 2 
(IPT) 
R2 Lifetime 
Cannabis Use 
Predictor β Std. Error Wald’s χ2 df p OR 95% CI 
.10 
Experimentala 
Sex (M vs. W) .09 .06 2.07 1 .15 1.09 .97-1.23 
Race (W vs. B) .36 .07 24.23 1 <.001 1.44* 1.24-1.66 
Race (W vs. A) 1.10 .09 146.08 1 <.001 3.02* 2.52-3.61 
Race (W vs. O) .27 .09 9.81 1 .002 1.31 1.11-1.55 
Cohort (1 vs. 2) .03 .08 .11 1 .74 1.03 .86-1.20 
Cohort (1 vs. 3) .00 .08 .00 1 .97 1.00 .85-1.17 
Cohort (1 vs. 4) -.28 .08 12.64 1 <.001 .76* .65-.88 
IPT (No vs. Yes) -.53 .06 84.44 1 <.001 .59* .53-.66 
Problematicb 
Sex (M vs. W) .46 .05 86.98 1 <.001 1.59* 1.44-1.75 
Race (W vs. B) .76 .07 129.06 1 <.001 2.14* 1.88-2.45 
Race (W vs. A) 1.41 .08 313.84 1 <.001 4.09* 3.50-4.78 
Race (W vs. O) .24 .07 11.46 1 .001 1.27 1.10-1.45 
Cohort (1 vs. 2) -.17 .07 6.12 1 .01 .85 .74-.97 
Cohort (1 vs. 3) -.30 .07 20.09 1 <.001 .74* .65-.84 
Cohort (1 vs. 4) -.18 .07 6.62 1 .01 .84 .73-.96 
IPT (No vs. Yes) -.74 .05 230.16 1 <.001 .48* .43-.52 
Note: No lifetime cannabis use is the reference group for lifetime experimental and problematic cannabis use comparisons; * = p < 
.001; a = use 1-5 times, b = use ≥ 6 times; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O = 
Other = 1; cohort 1 = 0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1; IPT = interpersonal trauma, no = 0, yes = 1 
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Table 4. Model 3: Demographics, IPT, and Polysubstance Use Predicting Lifetime Experimental and Problematic Cannabis Use 
Model 3 
(Substance 
Use) 
R2 Lifetime 
Cannabis Use 
Predictor β Std. Error Wald’s χ2 df p OR 95% CI 
.20 
Experimentala 
Nicotine .08 .02 20.82 1 <.001 1.08* 1.05-1.12 
Alcohol .10 .03 9.76 1 .002 1.11 1.04-1.18 
Sex (M vs. W) .07 .06 1.19 1 .28 1.07 .95-1.20 
Race (W vs. B) .31 .08 16.74 1 <.001 1.36* 1.17-1.57 
Race (W vs. A) 1.06 .09 134.51 1 <.001 2.90* 2.42-3.47 
Race (W vs. O) .25 .09 8.30 1 .004 1.28 1.08-1.51 
Cohort (1 vs. 2) .02 .08 .07 1 .80 1.02 .87-1.19 
Cohort (1 vs. 3) -.02 .08 .06 1 .81 .98 .84-1.15 
Cohort (1 vs. 4) -.28 .08 13.19 1 <.001 .75* .65-.88 
IPT (No vs. Yes) -.51 .06 76.95 1 <.001 .60* .54-.68 
Problematicb 
Nicotine .22 .01 247.17 1 <.001 1.24* 1.21-1.27 
Alcohol .66 .03 517.02 1 <.001 1.93* 1.82-2.04 
Sex (M vs. W) .36 .05 47.14 1 <.001 1.44* 1.30-1.59 
Race (W vs. B) .47 .07 43.80 1 <.001 1.60* 1.39-1.84 
Race (W vs. A) 1.19 .08 205.47 1 <.001 3.29* 2.79-3.87 
Race (W vs. O) .12 .07 2.55 1 .11 1.13 .97-1.30 
Cohort (1 vs. 2) -.10 .07 2.07 1 .15 .90 .79-1.04 
Cohort (1 vs. 3) -.28 .07 15.80 1 <.001 .75* .66-.87 
Cohort (1 vs. 4) -.12 .07 2.86 1 .09 .88 .76-1.02 
IPT (No vs. Yes) -.64 .05 152.22 1 <.001 .53* .47-.58 
Note: No lifetime cannabis use is the reference group for lifetime experimental and problematic cannabis use comparisons; * = p < 
.001; a = use 1-5 times, b = use ≥ 6 times; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O = 
Other = 1; cohort 1 = 0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1; IPT = interpersonal trauma, no = 0, yes = 1
Post-Hoc Analyses 
 In an attempt to tease apart the individual effects of nicotine and alcohol regarding 
polysubstance use, two additional multinomial logistic regressions were employed. Specifically, 
one model examined nicotine use frequency as a predictor of lifetime cannabis use threshold 
without alcohol use frequency, and the other model examined alcohol use frequency as a 
predictor of lifetime cannabis use threshold without nicotine use frequency.  
 Model 4 (see Table 5) tested sex, race, cohort, lifetime IPT exposure, and past 30-day 
nicotine use frequency as predictors of lifetime experimental and problematic cannabis use. 
Findings were consistent with Model 3 such that past 30-day nicotine use frequency remained a 
significant predictor of both lifetime experimental and problematic cannabis use. Model 5 (see 
Table 6) tested sex, race, cohort, lifetime IPT exposure, and past year alcohol use frequency as 
predictors of lifetime experimental and problematic cannabis use. Findings differed from Model 
3 such that past year alcohol use frequency became a significant predictor of both lifetime 
experimental and problematic cannabis use opposed to only lifetime problematic cannabis use. In 
summary, results suggest that past 30-day nicotine use frequency was accounting for a unique 
variance when both nicotine and alcohol use frequency were included as predictors of lifetime 
experimental cannabis use in Model 3, but alcohol use frequency only accounted for a significant 
amount of variance when it was included as a predictor without nicotine use frequency.
Table 5. Post-Hoc Model 4: Demographics, IPT, and Nicotine Use Predicting Lifetime Experimental and Problematic Cannabis Use 
 
Model 4 
(Nicotine 
Only) 
R2 Lifetime 
Cannabis Use 
Predictor β Std. Error Wald’s χ2 df p OR 95% CI 
.15 
Experimentala 
Nicotine .09 .02 25.40 1 <.001 1.09* 1.05-1.13 
Sex (M vs. W) .07 .06 1.18 1 .28 1.07 .95-1.20 
Race (W vs. B) .32 .07 18.59 1 <.001 1.38* 1.19-1.59 
Race (W vs. A) 1.08 .09 139.11 1 <.001 2.94* 2.46-3.52 
Race (W vs. O) .26 .09 9.10 1 .003 1.29 1.10-1.53 
Cohort (1 vs. 2) .02 .08 .09 1 .76 1.02 .88-1.20 
Cohort (1 vs. 3) -.02 .08 .05 1 .82 .98 .84-1.15 
Cohort (1 vs. 4) -.29 .08 13.44 1 <.001 .75* .65-.88 
IPT (No vs. Yes) -.51 .06 78.44 1 <.001 .60* .54-.67 
Problematicb 
Nicotine .26 .01 406.21 1 <.001 1.30* 1.27-1.34 
Sex (M vs. W) .38 .05 54.47 1 <.001 1.46* 1.32-1.61 
Race (W vs. B) .59 .07 73.26 1 <.001 1.80* 1.57-2.06 
Race (W vs. A) 1.32 .08 263.07 1 <.001 3.73* 3.18-4.37 
Race (W vs. O) .20 .07 8.03 1 .005 1.23 1.06-1.41 
Cohort (1 vs. 2) -.18 .07 6.93 1 .008 .83 .73-.96 
Cohort (1 vs. 3) -.36 .07 27.40 1 <.001 .70* .61-.80 
Cohort (1 vs. 4) -.21 .07 9.04 1 .003 .81 .70-.93 
IPT (No vs. Yes) -.67 .05 179.37 1 <.001 .51* .46-.56 
Note: No lifetime cannabis use is the reference group for lifetime experimental and problematic cannabis use comparisons; * = p < 
.001; a = use 1-5 times, b = use ≥ 6 times; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O = 
Other = 1; cohort 1 = 0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1; IPT = interpersonal trauma, no = 0, yes = 1 
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Table 6. Post-Hoc Model 5: Demographics, IPT, and Alcohol Use Predicting Lifetime Experimental and Problematic Cannabis Use 
 
Model 5 
(Alcohol 
Only) 
R2 Lifetime 
Cannabis Use 
Predictor β Std. Error Wald’s χ2 df p OR 95% CI 
.18 
Experimentala 
Alcohol .12 .03 14.11 1 <.001 1.13* 1.06-1.20 
Sex (M vs. W) .08 .06 1.98 1 .16 1.09 .97-1.22 
Race (W vs. B) .34 .07 20.99 1 <.001 1.40* 1.21-1.62 
Race (W vs. A) 1.08 .09 139.25 1 <.001 2.95* 2.46-3.53 
Race (W vs. O) .25 .09 8.79 1 .003 1.29 1.09-1.52 
Cohort (1 vs. 2) .03 .08 .10 1 .76 1.03 .88-1.20 
Cohort (1 vs. 3) .00 .08 .00 1 .97 1.00 .85-1.17 
Cohort (1 vs. 4) -.27 .08 12.11 1 .001 .76 .66-.89 
IPT (No vs. Yes) -.52 .06 81.73 1 <.001 .60* .53-.67 
Problematicb 
Alcohol .73 .03 660.87 1 <.001 2.07* 1.96-2.19 
Sex (M vs. W) .43 .05 68.51 1 <.001 1.54* 1.39-1.70 
Race (W vs. B) .60 .07 72.70 1 <.001 1.81* 1.58-2.08 
Race (W vs. A) 1.25 .08 232.77 1 <.001 3.50* 2.98-4.11 
Race (W vs. O) .14 .07 3.54 1 .06 1.15 .99-1.32 
Cohort (1 vs. 2) -.08 .07 1.41 1 .23 .92 .80-1.06 
Cohort (1 vs. 3) -.23 .07 10.39 1 .001 .80 .70-.92 
Cohort (1 vs. 4) -.09 .07 1.52 1 .22 .92 .80-1.05 
IPT (No vs. Yes) -.69 .05 182.94 1 <.001 .50* .45-.55 
Note: No lifetime cannabis use is the reference group for lifetime experimental and problematic cannabis use comparisons; * = p < 
.001; a = use 1-5 times, b = use ≥ 6 times; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O = 
Other = 1; cohort 1 = 0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1; IPT = interpersonal trauma, no = 0, yes = 1 
Aim 1b(i): Prevalence Estimates of Lifetime Interpersonal Trauma Exposure 
 Among those who reported lifetime IPT exposure at year 1 Fall (n = 3549, 35.9%), 
exposure to only one of the three experiences (i.e., physical assault, sexual assault, or other) of 
IPT was the most common. Specifically, 2378 participants (67.0%) reported a history of 
experiencing one of the three types of IPT. 789 participants (22.2.0%) reported a history of 
experiencing two types of IPT. 382 participants (10.8%) reported a history of experiencing all 
three types of IPT. 
Aim 1b(ii): Predictors of Lifetime Interpersonal Trauma Exposure 
Model Building Approach: Multivariate Analyses Predicting Lifetime Interpersonal 
Trauma Exposure 
 Logistic regression was used to examine whether demographics, alcohol use, nicotine 
use, and cannabis use predict lifetime IPT exposure assessed at year 1 Fall. All effect sizes are 
reported as odds ratios, which can be interpreted as the relative odds (compared to the reference 
group of no lifetime IPT exposure) of reporting lifetime IPT exposure. 
 Model 1 (see Table 7) tested sex, race, and cohort as predictors of lifetime IPT exposure. 
Sex, race, and cohort were all significant predictors of lifetime IPT exposure. Specifically, 
women were more likely to report a history of IPT exposure compared to men; White individuals 
were more likely to report a history of IPT exposure compared to Asian individuals; and cohorts 
two, three, and four were less likely to report a history of IPT compared to cohort one. 
 Model 2 (see Table 8) expanded the demographic variables in the initial model to include 
the effects of lifetime cannabis use in the prediction of lifetime IPT exposure. Sex and cohort 
were consistent with Model 1 regarding lifetime IPT exposure. Race was no longer a significant 
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predictor of lifetime IPT exposure. Individuals who did not report a history of cannabis use were 
less likely to report a history of IPT compared to individuals who reported lifetime cannabis use. 
 Model 3 (see Table 9) added the effect of past 30-day nicotine and past year alcohol use 
frequency in addition to the variables described in Model 2 in the prediction of lifetime IPT 
exposure. Sex, race, cohort, and lifetime cannabis use were consistent with Model 2 regarding 
lifetime IPT exposure. Alcohol was not a significant predictor of lifetime IPT exposure. Nicotine 
was a significant predictor of lifetime IPT exposure. Specifically, individuals who reported 
smoking more cigarettes during the past month were more likely to report lifetime IPT exposure. 
  
Table 7. Model 1: Demographics Predicting Lifetime Interpersonal Trauma Exposure 
Model 1 
(Demographics) 
R2 Predictor β Std. 
Error 
Wald’s χ2 df p OR 95% CI 
.02 
Sex (M vs. W) -.35 .04 68.88 1 <.001 .71* .65-.77 
Race (W vs. B) .10 .05 3.10 1 .08 1.10 .99-1.22 
Race (W vs. A) .36 .06 38.08 1 <.001 1.43* 1.28-1.60 
Race (W vs. O) -.12 .06 4.08 1 .04 .88 .78-1.00 
Cohort (1 vs. 2) .21 .06 14.07 1 <.001 1.23* 1.11-1.38 
Cohort (1 vs. 3) .21 .06 13.31 1 <.001 1.23* 1.10-1.37 
Cohort (1 vs. 4) .24 .06 17.08 1 <.001 1.27* 1.13-1.42 
Note: * = p < .001; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O = Other = 1; cohort 1 = 
0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1 
 
 
Table 8. Model 2: Demographics and Cannabis Use Predicting Lifetime Interpersonal Trauma Exposure 
 
Model 2 
(Cannabis Use) 
R2 Predictor β Std. 
Error 
Wald’s χ2 df p OR 95% CI 
.05 
Sex (M vs. W) -.40 .04 86.79 1 <.001 .67* .62-.73 
Race (W vs. B) .00 .06 0.00 1 .99 1.00 .90-1.11 
Race (W vs. A) .16 .06 7.54 1 .006 1.18 1.05-1.33 
Race (W vs. O) -.16 .06 6.92 1 .009 .85 .75-.96 
Cohort (1 vs. 2) .22 .06 15.61 1 <.001 1.25* 1.12-1.40 
Cohort (1 vs. 3) .24 .06 16.91 1 <.001 1.27* 1.13-1.42 
Cohort (1 vs. 4) .27 .06 21.65 1 <.001 1.31* 1.17-1.47 
Cannabis 
(No vs. Yes) 
-.66 .04 241.49 1 <.001 .52* .48-.56 
Note: * = p < .001; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O = Other = 1; cohort 1 = 
0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1; cannabis = lifetime cannabis use,  no = 0, yes = 1 
Table 9. Model 3: Demographics and Polysubstance Use Predicting Lifetime Interpersonal Trauma Exposure 
Model 3 
(Substance 
Use) 
R2 Predictor β Std. Error Wald’s χ2 df p OR 95% CI 
.06 
Nicotine .07 .01 39.75 1 <.001 1.08* 1.05-1.10 
Alcohol .07 .02 10.27 1 .001 1.08 1.03-1.13 
Sex (M vs. W) -.43 .04 98.19 1 <.001 .65* .60-.71 
Race (W vs. B) -.06 .06 1.22 1 .27 .94 .84-1.05 
Race (W vs. A) .12 .06 4.21 1 .04 1.13 1.01-1.27 
Race (W vs. O) -.18 .06 8.48 1 .004 .83 .74-.94 
Cohort (1 vs. 2) .23 .06 15.91 1 <.001 1.26* 1.12-1.40 
Cohort (1 vs. 3) .23 .06 15.77 1 <.001 1.26* 1.12-1.41 
Cohort (1 vs. 4) .27 .06 20.78 1 <.001 1.30* 1.16-1.46 
Cannabis 
(No vs. Yes) 
-.58 .04 174.63 1 <.001 .56* .51-.61 
Note: * = p < .001; Coding: M = men = 0, W = women = 1; W = White = 0, B = Black = 1, A = Asian = 1, O = Other = 1; cohort 1 = 
0, cohort 2 = 1, cohort 3 = 1, cohort 4 = 1; cannabis = lifetime cannabis use,  no = 0, yes = 1 
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Data Analytic Plan: Aims 2 and 3 
Aims 2 and 3 Analyses. Analyses for Aims 2 and 3 used continuous (e.g., cannabis use 
threshold and IPT exposure count) predictors and outcomes as well as continuous (e.g., age) 
covariates that were mean-centered in order to reduce non-essential multicollinearity and 
increase interpretability of the findings (Cohen, Cohen, West, & Aiken, 2003). The cannabis use 
threshold variable is an ordered categorical variable (i.e., 0 = no use, 1 = experimental use, 2 = 
problematic use) with higher values indicating greater use, however it was treated as continuous 
for the purposes of these analyses. Analyses for Aims 2 and 3 also used categorical (e.g., sex) 
covariates. Tests for univariate and multivariate outliers in the predictor variables were 
performed. Specifically, DFBETAS and studentized deleted residuals were utilized to determine 
whether there were any outlying cases (Neter, Wasserman, & Kutner, 1989). Distributional 
properties of all continuous variables were analyzed to ensure normal distribution of variables. 
Skewness and kurtosis values were examined for continuous variables to ensure that they fell 
within acceptable ranges (+/-2, +/-7, respectively; (Byrne, 2013; George & Mallery, 2016)). 
Main effects of covariates on the outcome variables (e.g., cannabis use threshold and IPT 
exposure count) were analyzed; when main effects of covariates were significant (p < .001) they 
were retained in the model. Interactions between covariates and covariates (e.g., sex and age), 
covariates and predictors (e.g., sex and cannabis use threshold) for Aims 2 and 3, and predictors 
and predictors (e.g., cannabis use threshold and IPT exposure count) specifically for Aim 3 were 
tested. Only significant interactions (p < .001) were retained in the model. All models testing 
Aims 2 and 3 were estimated in Mplus Version 8 (Muthen & Muthen, 2017), with mediation 
within Aim 3 being tested using the Model Indirect function. 
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Aim 2 tested the longitudinal associations between cannabis use threshold and IPT 
exposure count, over and above covariates. To test Aim 2, cross-lagged path analyses were 
conducted to test the hypotheses that (2a) year 1 Fall IPT exposure count is prospectively and 
positively associated with year 1 Spring cannabis use threshold and (2b) year 1 Fall cannabis use 
threshold is prospectively and positively associated with year 1 Spring IPT exposure count. 
Broadly, year 1 Fall cannabis use threshold and IPT exposure count were entered as a priori 
predictors of year 1 Spring IPT exposure count and cannabis use threshold, respectively. The 
covariates were age, sex, race, cohort, alcohol use frequency, and nicotine use frequency. 
Specifically, to test Aim 2a (i.e., longitudinal associations between IPT exposure count and 
cannabis use threshold, over and above covariates), significant covariates were entered into the 
model, followed by IPT exposure count, in order to test if IPT exposure count predicted cannabis 
use threshold over and above covariates. Specifically, to test Aim 2b (i.e., longitudinal 
associations between cannabis use threshold and IPT exposure count, over and above covariates), 
significant covariates were entered into the model, followed by cannabis use threshold, in order 
to test if cannabis use threshold significantly predicted IPT exposure count over and above 
covariates. 
Aim 3 proposed to model the longitudinal, and indirect, associations among IPT exposure 
count, probable PTSD, and cannabis use threshold to test the hypotheses that (3a) probable 
PTSD will mediate the relation between IPT exposure count and cannabis use threshold and (3b) 
IPT exposure count will mediate the relation between cannabis use threshold and probable 
PTSD. Specifically, a model building approach was employed, in which two different mediation 
analyses (i.e., one for both parts of Aim 3) were run simultaneously and tested (3a) whether IPT 
exposure count is associated with probable PTSD, and in turn increased cannabis use threshold 
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(i.e., self-medication hypothesis), as well as (3b) whether cannabis use threshold is associated 
with new IPT exposure count, and in term probable PTSD (i.e., high-risk hypothesis). The 
covariates were age, sex, race, alcohol use frequency, and nicotine use frequency. Covariates 
significantly associated with the outcomes (p < .001) were retained in the final model. In order to 
test study hypotheses, mediation analyses investigated whether the indirect effects of IPT 
exposure count on cannabis use threshold through probable PTSD as well as cannabis use 
threshold on probable PTSD through IPT exposure count were significant. 
Determination of Model Fit. Path analyses rely on several statistical tests in order to 
determine the adequacy of model fit to the data. The Root Mean Square Error of Approximation 
(RMSEA) is related to residual in the model. RMSEA values range from 0 to 1 with a smaller 
RMSEA value indicating better model fit. Acceptable model fit is indicated by an RMSEA value 
of 0.06 or less (Hu & Bentler, 1999). The Comparative Fit Index (CFI) compares the fit of a 
target model to the fit of a null model. CFI ranges from 0 to 1 with a larger value indicating 
better model fit. Acceptable model fit is indicated by a CFI value of 0.90 or greater (Hu & 
Bentler, 1999). The Tucker-Lewis Index (TLI) is an incremental fit index preferable for smaller 
sample sizes. TLI ranges from 0 to 1 with a larger value indicating better model fit.  
Aims 2 and 3 Participant Characteristics 
 Descriptive statistics are presented in Table 10. Prevalence of experimental and 
problematic cannabis use upon college entry (i.e., Year 1 Fall) was 17.4% (n = 1718) and 28.1% 
(n = 2780), respectively. Prevalence of lifetime IPT exposure count upon college entry for 1, 2, 
and 3 types was 29.2% (n = 2890 for 1 type), 12.5% (n = 1240 for 2 types), and 6.5% (n = 642 
for 3 types), respectively. Prevalence of probable PTSD upon college entry was 32.2% (n = 
3186). Prevalence of experimental and problematic cannabis use during approximately the past 
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six months assessed at Year 1 Spring was 19.1% (n = 1888) and 22.6% (n = 2240), respectively. 
Prevalence of new onset IPT exposure count during approximately the past six months assessed 
at Year 1 Spring for 1, 2, and 3 types was 16.6% (n = 1645), 4.4% (n = 438), and 1.6% (n = 161), 
respectively. Prevalence of probable PTSD assessed at Year 1 Spring was 29.2% (n = 2887). 
Prevalence of experimental and problematic cannabis use during approximately the past year 
assessed at Year 2 Spring was 17.6% (n = 1744) and 26.9% (n = 2657), respectively. Prevalence 
of new onset IPT exposure count during approximately the past year assessed at Year 2 Spring 
for 1, 2, and 3 types was 13.9% (n = 1370), 2.4% (n = 234), and 0.6% (n = 62), respectively. 
Prevalence of probable PTSD assessed at Year 2 Spring was 30.7% (n = 3035). 
Table 10. Clinical Characteristics at Year 1 Fall, Year 1 Spring, and Year 2 Spring 
 Year 1 Fall Year 1 Spring Year 2 Spring 
Variable Category n (%) Category n (%) Category n (%) 
Cannabis 
Use 
Threshold 
None 5393 (54.5%) None 5763 (58.3%) None 5490 (55.5%) 
Experimental 1718 (17.4%) Experimental 1888 (19.1%) Experimental 1744 (17.6%) 
Problematic 2780 (28.1%) Problematic 2240 (22.6%) Problematic 2657 (26.9%) 
IPT 
Exposure 
Count 
0 5119 (51.8%) 0 7647 (77.3%) 0 8225 (83.2%) 
1 2890 (29.2%) 1 1645 (16.6%) 1 1370 (13.9%) 
2 1240 (12.5%) 2 438 (4.4%) 2 234 (2.4%) 
3 642 (6.5%) 3 161 (1.6%) 3 62 (0.6%) 
Probable 
PTSD 
No 6703 (67.8%) No 7004 (70.8%) No 6856 (69.3%) 
Yes 3186 (32.2%) Yes 2887 (29.2%) Yes 3035 (30.7%) 
Note: IPT = Interpersonal Trauma, PTSD = Posttraumatic Stress Disorder 
Aim 2 Model Fit 
 The path analysis, with covariates such as sex, race, age, cohort, and alcohol and nicotine 
use, produced a decent to good fitting model χ2 (8) = 530.05, p < .001; RMSEA = 0.08, CFI = 
0.92, and TLI = 0.43. To improve model fit, modification indices were considered. However, 
paths that were recommended to improve model fit were theoretically irrational (i.e., year 1 Fall 
cannabis on year 1 Spring cannabis, year 1 Fall IPT with year 1 Spring cannabis) and were thus 
not incorporated into the model. The path coefficients of this model are presented in Table 11.  
Aim 2 Outlier Analyses 
 There were no univariate outliers based on DFBETAS or multivariate outliers based on 
studentized deleted residuals (SDRs) (Cohen et al., 2003). The cut-off value for DFBETAS is 
2/sqrt(n), where n is the number of observations (n = 9889). No cases exceeded a DFBETAS cut-
off value of 0.02, but we removed the top three cases with the largest values of DFBETAS. Since 
SDRs have a t-distribution, an SDR of magnitude 3 or more in absolute value will be considered 
an outlier. No cases exceed a SDR cut-off value of 3 in absolute value, but we removed the top 
three cases with the largest values of SDRs. The model results did not change after the most 
influential cases were removed. Thus, the confidence in the findings not being driven by single 
cases was increased. Results of the path analysis are presented in Table 11 and detailed below. 
Cross-Lagged Panel Model Examining Cannabis Use and IPT Count 
Aim 2a: Association between Year 1 Fall IPT and Year 1 Spring cannabis use (Self-Medication 
Hypothesis) 
 Age was not a significant predictor of year 1 Fall cannabis use. Sex was a significant 
predictor of year 1 Fall cannabis use, such that women were less likely to report a greater number 
of times using cannabis compared to men. Race was a significant predictor of year 1 Fall 
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cannabis use, such that Black and Asian individuals were less likely to report a greater number of 
times using cannabis at year 1 Fall compared to White individuals. Cohort three was more likely 
to report a greater number of times using cannabis at year 1 Fall compared to cohort one. Both 
alcohol and nicotine use were significant predictors of year 1 Fall cannabis use, such that 
individuals who reported more frequent alcohol and nicotine use were more likely to report a 
greater number of times using cannabis at year 1 Fall. 
 Year 1 Spring cannabis use was predicted by year 1 Fall IPT above and beyond year 1 
Fall cannabis use and covariates. Specifically, individuals who reported experiencing more types 
of IPT at year 1 Fall were more likely to report a greater number of times using cannabis at year 
1 Spring. Race and age were not significant predictors of year 1 Spring cannabis use. Year 1 Fall 
cannabis use was a significant predictor of year 1 Spring cannabis use, such that individuals who 
reported a greater number of times using cannabis at year 1 Fall were more likely to report a 
greater number of times using cannabis at year 1 Spring. Sex was a significant predictor of year 1 
Spring cannabis use, such that women were less likely to report a greater number of times using 
cannabis compared to men. Cohort three was more likely to report a greater number of times 
using cannabis at year 1 Spring compared to cohort one. Alcohol and nicotine use were 
significant predictors of cannabis use at year 1 Spring. Specifically, individuals who reported 
more frequent alcohol and nicotine use at year 1 Spring were more likely to report a greater 
number of times using cannabis at year 1 Spring.  
Aim 2b: Association between Year 1 Fall cannabis use and Year 1 Spring IPT (High-Risk 
Hypothesis) 
 Race, cohort, and age were not significant predictors of year 1 Fall IPT count. Sex was a 
significant predictor of year 1 Fall IPT count, such that women were more likely to report 
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experiencing more types of IPT compared to men. Both alcohol and nicotine use were significant 
predictors of year 1 Fall IPT count, such that individuals who reported more frequent alcohol and 
nicotine use were more likely to report experiencing more types of IPT at year 1 Fall. 
 Year 1 Spring IPT count was not predicted by year 1 Fall cannabis use above and beyond 
year 1 Fall IPT count and covariates. Sex, race, cohort, age, and alcohol use were not significant 
predictors of year 1 Spring IPT count. Year 1 Fall IPT count was a significant predictor of year 1 
Spring IPT count, such that individuals who reported experiencing more types of IPT at year 1 
Fall were more likely to report experiencing more types of IPT at year 1 Spring. Nicotine use 
was a significant predictor of IPT count at year 1 Spring. Specifically, individuals who reported 
more frequent nicotine use at year 1 Spring were more likely to report experiencing more types 
of IPT at year 1 Spring.  
Table 11. IPT Predicting Cannabis Use (Self-Medication Hypothesis) and Cannabis Use Predicting IPT (High-Risk Hypothesis) Path 
Analysis Results 
 
Predictors 
Cannabis Use Threshold IPT Count 
Y1F Y1S Y1F Y1S 
β S.E. p β S.E. p β S.E. p β S.E. p 
Sex (Women) -.05 .01 < .001* -.05 .01 < .001* .15 .01 < .001* .01 .01 .41 
Race (Black) -.07 .01 < .001* .02 .01 .07 .01 .01 .79 .01 .01 .14 
Race (Asian) -.17 .01 < .001* -.02 .01 .03 -.03 .01 .001 .01 .01 .45 
Race (Other) -.02 .01 .08 .02 .01 .02 .03 .01 .02 -.01 .01 .25 
Age .00 .01 .67 -.02 .01 .01 .01 .01 .31 -.01 .01 .25 
Cohort (2) .01 .01 .22 .01 .01 .42 -.04 .01 .001 .01 .01 .13 
Cohort (3) .04 .01 < .001* .05 .01 < .001* -.04 .01 .003 -.01 .01 .75 
Cohort (4) .02 .01 .06 .04 .01 .001 -.04 .01 .001 .01 .01 .15 
Alcohol (Y1F) .23 .01 < .001* - - - .07 .01 < .001* - - - 
Alcohol (Y1S) - - - .15 .01 < .001* - - - .02 .01 .05 
Nicotine (Y1F) .17 .01 < .001* - - - .11 .01 < .001* - - - 
Nicotine (Y1S) - - - .07 .01 < .001* - - - .03 .01 < .001* 
Cannabis (Y1F) - - - .43 .01 < .001* - - - .02 .01 .04 
IPT (Y1F)  - - - .03 .01 < .001* - - - .62 .01 < .001* 
Note: IPT = Interpersonal Trauma, Sex (Reference: Male), Race (Reference: White), Cohort (Reference: 1), Y1F = Year 1 Fall, Y1S = 
Year 1 Spring, * significant at p < .001
Aim 3 Model Fit 
 The path analysis, with covariates such as sex, race, age, cohort, and alcohol and nicotine 
use, produced a poor fitting model χ2 (33) = 6470.76, p < .001; RMSEA = 0.14, CFI = 0.14, and 
TLI = -1.07. To improve model fit, modification indices were considered. However, paths that 
were recommended to improve model fit were theoretically irrational (i.e., year 1 Fall probable 
PTSD on year 2 Spring probable PTSD, year 1 Spring IPT count with year 1 Spring probable 
PTSD) and thus were not added to the model. The path coefficients of this model are presented 
in Table 12. 
Aim 3 Outlier Analyses 
 There were no univariate outliers based on DFBETAS or multivariate outliers based on 
studentized deleted residuals (SDRs) (Cohen et al., 2003). No cases exceeded a DFBETAS cut-
off value of 0.02, but we removed the top three cases with the largest values of DFBETAS. No 
cases exceed a DFBETAS cut-off value of 3 in absolute value, but we removed the top three 
cases with the largest values of SDRs. The model results did not change after the most influential 
cases were removed one at a time. Thus, the confidence in the findings not being driven by 
single cases was increased. Results of the path analysis are presented in Table 12 and detailed 
below. 
Cross-Lagged Panel Model Examining Cannabis Use, IPT Count, and Probable PTSD 
Aim 3a: Mediational association between Year 1 Fall IPT count, Year 1 Spring probable PTSD, 
and Year 2 Spring cannabis use threshold (High-Risk Hypothesis) 
 Sex was a significant predictor of year 1 Spring probable PTSD, such that women were 
more likely to meet criteria for probable PTSD compared to men. Race was a significant 
predictor of year 1 Spring probable PTSD, such that Black and Asian individuals were less likely 
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to meet criteria for probable PTSD compared to White individuals. Cohorts two, three, and four 
were more likely to meet criteria for probable PTSD at year 1 Spring compared to cohort one. 
Age was a significant predictor of year 1 Spring probable PTSD, such that older individuals were 
more likely to meet criteria for probable PTSD at year 1 Spring. Nicotine use was a significant 
predictor of year 1 Spring probable PTSD, such that individuals who reported more frequent 
nicotine use were more likely to meet criteria for probable PTSD at year 1 Spring. Alcohol use 
was not significant a predictor of probable PTSD at year 1 Spring. IPT count was a significant 
predictor of year 1 Spring probable PTSD, such that individuals who reported experiencing more 
types of IPT exposure at year 1 Fall were more likely to meet criteria for probable PTSD at year 
1 Spring. 
 Sex, cohort, and age were not significant predictors of year 2 Spring cannabis use. Race 
was a significant predictor of year 2 Spring cannabis use, such that Asian individuals were less 
likely to report a greater number of times using cannabis compared to White individuals. Both 
nicotine and alcohol use were significant predictors of year 2 Spring cannabis use, such that 
individuals who reported more frequent nicotine use were more likely to report experimental or 
problematic cannabis use at year 2 Spring. IPT count was a significant predictor of year 2 Spring 
cannabis use, such that individuals who reported more types of IPT exposure at year 1 Fall were 
more likely to report a greater number of times using cannabis at year 2 Spring. Probable PTSD 
was not a significant predictor of year 2 Spring cannabis use. 
In examining whether year 1 Spring probable PTSD mediated the effect of year 1 Fall 
IPT count on year 2 Spring cannabis use, we found that the indirect effect was non-significant (β 
= -.01, 95% CI: -.020 - -.002, p = .01). Therefore, year 1 Spring probable PTSD did not mediate 
the effect of year 1 Fall IPT count on year 2 Spring cannabis use.
Aim 3b: Mediational association between Year 1 Fall cannabis use threshold, Year 1 Spring IPT 
count, and Year 2 Spring probable PTSD (High-Risk Hypothesis) 
 Sex, race, cohort, age, nicotine use, and cannabis use were not significant predictors of 
year 1 Spring IPT count. Alcohol was a significant predictor of year 1 Spring IPT count, such 
that individuals who reported more frequent alcohol use were more likely to report experiencing 
more IPT at year 1 Spring. 
 Alcohol and cannabis use were not significant predictors of probable PTSD at year 2 
Spring. Sex was a significant predictor of year 2 Spring probable PTSD, such that women were 
more likely to meet criteria for probable PTSD compared to men. Race was a significant 
predictor of year 2 Spring probable PTSD, such that Other individuals were more likely to meet 
criteria for probable PTSD at year 2 Spring compared to White individuals. Cohorts two, three, 
and four were more likely to meet criteria for probable PTSD at year 2 Spring compared to 
cohort one. Age was a significant predictor of year 2 Spring probable PTSD, such that older 
individuals were more likely to meet criteria for probable PTSD at year 2 Spring. Nicotine use 
was a significant predictor of year 2 Spring probable PTSD, such that individuals who reported 
more frequent nicotine use were less likely to meet criteria for probable PTSD at year 2 Spring. 
IPT count was a significant predictor of year 2 Spring probable PTSD, such that individuals who 
reported experiencing more types of new onset IPT exposure between year 1 Fall and year 1 
Spring were more likely to meet criteria for probable PTSD at year 2 Spring. 
In examining whether year 1 Spring IPT count mediated the effect of year 1 Fall cannabis 
use on year 2 Spring probable PTSD, we found that the indirect effect was non-significant (β = 
.00, 95% CI: -.001 - .003, p = .19). Therefore, year 1 Spring IPT count did not mediate the effect 
of year 1 Fall cannabis use on year 2 Spring probable PTSD.
Table 12. Probable PTSD as a Mediator Between IPT and Cannabis Use (Self-Medication Hypothesis) and IPT as a Mediator 
Between Cannabis Use and Probable PTSD (High-Risk Hypothesis) Path Analysis Results 
Predictors 
Self-Medication Hypothesis High-Risk Hypothesis 
PTSD (Y1S) Cannabis (Y2S) IPT (Y1S) PTSD (Y2S) 
β S.E. p β S.E. p β S.E. p β S.E. p 
Sex (Women) .17 .01 < .001* -.02 .01 .02 .01 .01 .43 .17 .01 < .001* 
Race (Black) -.06 .01 < .001* -.02 .01 .05 .02 .01 .10 .00 .01 .76 
Race (Asian) -.06 .01 < .001* -.05 .01 < .001* .01 .01 .38 .04 .01 .006 
Race (Other) .01 .01 .66 .00 .01 .95 -.01 .01 .28 .06 .01 < .001* 
Cohort (2) .06 .02 < .001* .01 .01 .59 .02 .01 .17 .06 .02 < .001* 
Cohort (3) .14 .02 < .001* .00 .01 .80 -.01 .01 .65 .09 .02 < .001* 
Cohort (4) .15 .02 < .001* .01 .01 .68 .02 .01 .18 .13 .02 < .001* 
Age .09 .01 < .001* .01 .01 .64 -.01 .01 .30 .05 .01 < .001* 
Nicotine (Y1F) .08 .02 < .001* - - - .00 .01 .95 - - - 
Nicotine (Y1S) - - - .10 .01 < .001* - - - -.10 .02 < .001* 
IPT (Y1F) .29 .01 < .001* .06 .01 < .001* - - - - - - 
IPT (Y1S) - - - - - - - - - .08 .01 < .001* 
PTSD (Y1F) - - - - - - - - - - - - 
PTSD (Y1S) - - - -.04 .02 .01 - - - - - - 
Note: IPT = Interpersonal Trauma, PTSD = Posttraumatic Stress Disorder, Sex (Reference: Male), Race (Reference: White), Cohort 
(Reference: 1), Y1F = Year 1 Fall, Y1S = Year 1 Spring, Y2S = Year 2 Spring, * significant at p < .001
Table 12 (cont.). Probable PTSD as a Mediator Between IPT and Cannabis Use (Self-Medication Hypothesis) and IPT as a Mediator 
Between Cannabis Use and Probable PTSD (High-Risk Hypothesis) Path Analysis Results 
Predictors 
Self-Medication Hypothesis High-Risk Hypothesis 
PTSD (Y1S) Cannabis (Y2S) IPT (Y1S) PTSD (Y2S) 
β S.E. p β S.E. p β S.E. p β S.E. p 
Cannabis (Y1F) - - - - - - .01 .01 .18 .00 .01 .99 
Alcohol (Y1F) .01 .01 .45 - - - .04 .01 <.001*** - - - 
Alcohol (Y1S) - - - .10 .01 < .001*** - - - .00 .01 .97 
Note: IPT = Interpersonal Trauma, PTSD = Posttraumatic Stress Disorder, Sex (Reference: Male), Race (Reference: White), Cohort 
(Reference: 1), Y1F = Year 1 Fall, Y1S = Year 1 Spring, Y2S = Year 2 Spring, * significant at p < .001
Discussion 
The aims of the present study were threefold. First, the present study examined the 
prevalence and predictors of lifetime cannabis use and lifetime IPT exposure. Second, the self-
medication and high-risk hypotheses were explored by investigating the bidirectional 
relationship between IPT count and cannabis use threshold over time. Third, the self-medication 
and high-risk hypotheses were further studied using a mediational framework. Specifically, the 
self-medication hypothesis was investigated by testing the indirect effect of IPT count onto 
cannabis use threshold via probable PTSD. Likewise, the high-risk hypothesis was investigated 
by testing the indirect effect of cannabis use threshold onto probable PTSD via IPT count. 
Findings from each aim are discussed in turn. 
Aim 1a: Prevalence and Predictors of Lifetime Cannabis Use 
Overall Summary of Findings 
 This study estimated the prevalence of lifetime cannabis use and investigated 
demographic and clinical characteristics as predictors of lifetime cannabis use, which produced 
four main findings. First, results showed that individuals who reported a history of IPT exposure 
prior to college were more likely to report lifetime experimental and problematic cannabis use. 
Second, results showed evidence for sex differences with respect to lifetime cannabis use, such 
that men were more likely to report a history of problematic cannabis use compared to women, 
but not experimental cannabis use. Third, results showed evidence for racial differences with 
respect to lifetime cannabis use, such that White individuals were more likely to report a history 
of experimental and problematic cannabis use compared to Black and Asian individuals. Fourth, 
results showed evidence for lifetime alcohol and nicotine use as predictors of lifetime cannabis 
use. 
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Prevalence of Lifetime Cannabis Use 
 The present study assessed the prevalence of lifetime experimental and problematic 
cannabis use among a large sample of college students at an urban college campus in the 
southeastern part of the United States. Overall, 17.4% and 28.3% of participants reported 
lifetime experimental and problematic cannabis use, respectively. These findings were consistent 
with previous prevalence estimates, which suggested that almost half (45%) of incoming college 
students report lifetime cannabis use (Arria et al., 2017). Our study separated lifetime cannabis 
use into categories based on total number of times used (i.e., experimental = use 1-5 times, 
problematic = use ≥ 6 times), but combined, almost half (45.7%) of study participants reported a 
history of either category of cannabis use upon college entry. 
Predictors of Lifetime Cannabis Use 
 The present study also examined predictors of lifetime experimental and problematic 
cannabis use. Lifetime IPT exposure was hypothesized to predict lifetime cannabis use above 
and beyond demographic and substance use covariates. Consistent with previous research 
(Kevorkian et al., 2015; Konkoly Thege et al., 2017; Werner et al., 2016), results show that 
individuals who reported lifetime IPT exposure were more likely to report lifetime experimental 
and problematic cannabis use. IPT is a stronger predictor of psychopathology compared to 
accidental trauma (Frans et al., 2005; Kilpatrick et al., 2013). Although previous research 
supports trauma exposure broadly predicting cannabis use (Kevorkian et al., 2015), results from 
this study support IPT exposure as a category of trauma exposure that is a predictor of increased 
risk for cannabis use. Similar to Kevorkian and colleagues (2015), alcohol, but not nicotine, was 
included as a predictor of cannabis use along with trauma exposure. However, a recent study 
investigating the co- and tri-use of cannabis, cigarettes, and alcohol without trauma as a predictor  
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found that the use of cannabis, cigarettes, or alcohol independently increased the probability of 
subsequent, simultaneous co-use of one of the two remaining substances (Roche et al., 2019). 
Therefore, our study expanded the literature by including both alcohol and nicotine as predictors 
of cannabis use in order to help demonstrate that IPT is associated with increased risk over other 
established correlates. 
 As hypothesized, demographic factors were associated with risk of reporting lifetime 
cannabis use. Regarding sex, it was hypothesized that men would be more likely to report a 
history of cannabis use compared to women. Results show that men were more likely to report 
lifetime problematic cannabis use compared to women, but men and women were equally likely 
to report lifetime experimental cannabis use. Results align with previous research, which 
suggests that men are more likely to use cannabis than women, and the differences tend to be 
most severe at higher frequency levels (Carliner et al., 2017; Johnston et al., 2016; Substance 
Abuse and Mental Health Services Administration, 2016). This sex gap regarding cannabis use 
could be due to both biological and sociological differences, such as how cannabis use affects the 
body, addiction stigma, and societal expectations about emotional expression. Results also 
mirrored similar epidemiologic research that examined sex differences in prevalence of CUDs 
(Kerridge, Pickering, Chou, Saha, & Hasin, 2018). Therefore, results expanded the literature by 
demonstrating the level of use (i.e., experimental versus problematic) where sex differences are 
more likely to be detected among college students. 
 While there were racial differences among those who were more likely to report lifetime 
cannabis use, the racial differences were not in the hypothesized direction. Specifically, it was 
hypothesized that individuals belonging to racial minority groups would be more likely to report 
cannabis use compared to White individuals. Results show that White individuals were more 
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likely to report both experimental and problematic cannabis use compared to Black, Asian, and 
Other individuals. Regarding race as a predictor of cannabis use, previous research shows that 
racial and ethnic minority individuals are more likely to report using cannabis compared to 
White individuals (Pacek et al., 2012; Warner, 2016). Therefore, the race results of this study are 
inconsistent with previous research suggesting that racial minority individuals are less likely to 
use cannabis compared to White individuals. Among adolescents on the trajectory to college, 
recent epidemiological study results show a trend that cannabis use is increasing in the United 
States among non-White adolescents in the 10th through 12th grades (Keyes, Wall, Feng, Cerda, 
& Hasin, 2017). These self-report survey procedures have been shown to enhance valid reporting 
by collecting data via non-school-associated university personnel. While Spit for Science is also 
collected via self-report, it is subject to potentially more bias and error due to its affiliation with 
the university, which provides a possible explanation for the inconsistent findings. However, 
consistent with previous research (Johnson et al., 2015), results showed that Asian individuals 
were the racial group least likely to report cannabis use. Regardless of the levels of cannabis use 
among racial and ethnic minorities, these individuals are still more likely than White individuals 
to experience negative consequences of cannabis use, including CUD, negative psychosocial 
outcomes, and academic difficulties (Blavos et al., 2017; Edwards et al., 2015). 
  Additional covariates were explored as predictors of lifetime cannabis use. Cohorts 3 and 
4 were more likely to report lifetime problematic and experimental cannabis use, respectively, 
compared to cohort 1. These results are consistent with previous research suggesting that the 
overall prevalence of lifetime cannabis use is increasing among individuals 12 years and older 
and that younger generations are more likely to use cannabis compared to older generations due 
to increasing acceptance and legalization rates (Kilmer & MacCoun, 2017; Substance Abuse and 
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Mental Health Services Administration, 2016). In a related study investigating alcohol 
consumption and drinking to cope with trauma-related distress in the same sample, latter cohorts 
were overall more risky regarding their alcohol use (Bountress et al., 2019). Results from this 
study extended their overall more risky behavior to include cannabis use.  
Legal substances, such as nicotine and alcohol, were explored as predictors of lifetime 
cannabis use. Individuals who reported more frequent nicotine use during the past month were 
more likely to report lifetime experimental cannabis use. Additionally, individuals who reported 
more frequent nicotine use during the past month and more frequent alcohol use during the past 
year were more likely to report lifetime problematic cannabis use. Post-hoc analyses revealed 
that individuals who reported more frequent alcohol use during the past year were more likely to 
report both lifetime experimental and problematic cannabis use when past 30-day nicotine use 
frequency was not included as a predictor. These results are consistent with previous 
epidemiological research suggesting that cannabis use is more common among people who 
smoke cigarettes than among those who do not (Goodwin et al., 2018). However, results extend 
the literature by showing more frequent nicotine use is a better predictor of lifetime cannabis use 
among individuals with both frequent nicotine and alcohol use, which could be due to the similar 
route of administration (i.e., inhalation). Although a majority of previous research supports the 
association between more severe phenotypes such as lifetime nicotine use, alcohol use, and 
cannabis use disorders (Grant et al., 2016; Kevorkian et al., 2015), these results are still 
consistent such that a history of alcohol and nicotine are predictors of increased risk for lifetime 
cannabis use. 
Aim 1b: Prevalence and Predictors of Lifetime IPT Exposure 
Overall Summary of Findings 
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 This study estimated the prevalence of lifetime IPT exposure and investigated 
demographic and clinical characteristics as predictors of lifetime IPT exposure, which produced 
four main findings. First, results showed cross-sectional support for the high-risk hypothesis, 
such that individuals who reported a history of cannabis use were more likely to report lifetime 
IPT exposure. Second, results showed evidence for sex differences with respect to lifetime IPT 
exposure, such that women were more likely to report a history of IPT exposure compared to 
men. Third, results showed that all racial groups were equally likely to report a history of 
lifetime IPT exposure. Fourth, results showed evidence for nicotine use as a predictor of lifetime 
IPT exposure. 
Prevalence of Lifetime IPT Exposure 
 The present study assessed the prevalence of lifetime IPT exposure among college 
students. Overall, 35.9% of participants reported lifetime IPT exposure. This study’s findings 
were inconsistent with previous prevalence estimates, which suggested that about 50.6% of 
college students reported a history of IPT exposure (Read, Griffin, Wardell, & Ouimette, 2014). 
This inconsistency is likely due to the different ways trauma exposure was assessed. Read and 
colleagues (2014) used the Traumatic Life Events Questionnaire (TLEQ) to assess trauma 
exposure compared to Spit for Science’s Life Events Checklist (LEC). In contrast, 11 out of the 
21 items of the TLEQ map onto the definition of IPT opposed to 3 out of the 5 items of the 
modified LEC used in the present study. This lower prevalence estimate based on this study were 
likely due to lack of inclusion of other categories of IPT that are included in other measures, such 
as the TLEQ. 
Predictors of Lifetime IPT Exposure 
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 The present study also assessed predictors of lifetime IPT exposure. Lifetime cannabis 
use was hypothesized to predict lifetime IPT exposure above and beyond demographic and 
clinical covariates. Consistent with previous research investigating the association between 
lifetime cannabis use and lifetime trauma exposure (Kevorkian et al., 2015), results show that 
individuals with a history of cannabis use were more likely to report lifetime IPT exposure. 
 As hypothesized, there were demographic differences among those who were more likely 
to report lifetime IPT exposure. Results were consistent with the hypothesis that women would 
be more likely to report a history of IPT compared to men. Results align with previous research, 
which suggests that women are more likely to experience IPT than men in both college (Fedina, 
Holmes, & Backes, 2018; Read et al., 2011) and non-college (Benjet et al., 2016; Lilly & 
Valdez, 2012) samples. Results add to the substantial evidence that sex differences are universal 
regarding IPT exposure and that the college environment is no exception.  
 It was hypothesized that individuals belonging to racial minority groups would be more 
likely to report a history of IPT exposure compared to White individuals. Contrary to hypotheses, 
results indicate that there were no racial differences among those who reported lifetime IPT 
exposure. Although previous research has shown significant differences in IPT exposure across 
different racial and ethnic groups (Roberts et al., 2011), this study’s results show that all college 
students, regardless of race, are equally likely to report lifetime IPT exposure prior to college 
enrollment. This inconsistency is likely due to the different ways trauma exposure was assessed. 
Roberts and colleagues (2011) used data from structured diagnostic interviews of the National 
Epidemiologic Survey on Alcohol and Related Conditions (NESARC) to assess lifetime trauma 
exposure compared to Spit for Science’s LEC. In contrast, at least 6 out of the 27 items of the 
NESARC map onto the definition of IPT opposed to 3 out of the 5 items of the LEC. The equal 
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likelihood of individuals of different racial backgrounds having a history of IPT exposure based 
on this study could be due to having less specific and a lower variety of potential IPT events for 
participants to choose from during self-reported assessment of lifetime trauma exposure. Another 
possible explanation for the inconsistencies is that there may not be racial differences in IPT 
exposure among those seeking higher education compared to the general population. In a study 
examining trauma exposure of newly matriculated college students, Read and colleagues (2011) 
found that individuals from a non-White racial background were at higher risk for IPT exposure 
compared to White individuals. However, individuals who reported identifying as Black, Asian, 
Hispanic/Latino, American-Indian/Alaskan, Hawaiian/Pacific Islander, and Multiracial were 
grouped together for statistical analyses due to not ideal percentages of representation in most 
groups (i.e., < 10%). It is possible that racial differences may not have been found if analyses 
were conducted separately by larger racial groups. 
 Additional covariates were explored as predictors of lifetime IPT exposure. Cohorts 2, 3, 
and 4 were less likely to report a history of IPT exposure compared to cohort 1. Additionally, 
individuals who reported more frequent nicotine use during the past 30 days were more likely to 
report lifetime IPT exposure. These results are consistent with previous research, which indicate 
that current- and ever-smokers have increased odds of reporting experiencing traumatic events 
compared to never-smokers (Hapke et al., 2005). (Jamal et al., 2014), those who continue to 
smoke cigarettes could be classified as more risky individuals, and perhaps this may partially 
account for the increased risk for IPT exposure. Additionally, these analyses are cross-sectional, 
and thus order of onset cannot be determined. Thus, it could be that smoking behavior occurred 
subsequent to IPT exposure. There is a wealth of literature on increased smoking behaviors 
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among trauma and PTSD populations (Gabert-Quillen, Selya, & Delahanty, 2015; Kearns et al., 
2018; Pericot-Valverde, Elliott, Miller, Tidey, & Gaalema, 2018).  
Aim 2: Longitudinal Investigation of the Self-Medication and High-Risk Hypotheses 
 Overall Summary of Findings 
 The associations between lifetime cannabis use and lifetime IPT exposure speaks to the 
self-medication (Boden, Babson, Vujanovic, Short, & Bonn-Miller, 2013) and high-risk 
(Ramaekers, Berghaus, van Laar, & Drummer, 2004) hypotheses. According to the self-
medication hypothesis, cannabis use may serve as an avoidance function for those with an IPT 
history and could be coping with trauma-related symptoms. Conversely, the high-risk hypothesis 
purports that using cannabis may lead to higher risk for experiencing trauma exposure. The self-
medication and high-risk hypotheses can be used as a lens to try to understand the associations 
among cannabis use, trauma exposure, and PTSD, with longitudinal analyses allowing for 
methods by which one could examine links in these pathways. This study used these etiologic 
models of comorbid cannabis use and trauma-related phenotypes to investigate the relationships 
between lifetime IPT exposure and new onset cannabis use and lifetime cannabis use and new 
onset IPT exposure during the first year of college. Results supported the direction of effect from 
IPT to cannabis use, supporting the self-medication hypothesis, but not from IPT to cannabis use, 
not lending support to the high-risk hypothesis. 
Self-Medication Hypothesis 
 Path analyses suggest that IPT exposure is a significant predictor of cannabis use above 
and beyond race, age, nicotine, alcohol, and previous cannabis use. These results are consistent 
with previous research, which suggests that trauma exposure tends to precede, rather than follow, 
the development of lifetime cannabis use and cannabis use problems (Kevorkian et al., 2015), 
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specifically IPT (Browne, Dolan, Simpson, Fortney, & Lehavot, 2018; Werner et al., 2016). 
 Results from the current study expanded the trauma-related and cannabis use phenotypes 
self-medication literature with the use of longitudinal data and a college sample. Kevorkian and 
colleagues (2015) used a nationally-representative sample of adults in the U.S. to examine the 
association between lifetime trauma exposure, PTSD, cannabis use, and CUD and found that 
individuals exposed to trauma are at a higher risk of using cannabis or developing cannabis use 
problems compared to individuals without a history of trauma exposure. Although the direction 
of effect cannot be determined due to the cross-sectional nature of the study, results suggest that 
because trauma-exposed individuals had higher odds of reporting cannabis use than non-trauma 
exposed individuals, there is a unique association between trauma exposure and cannabis use 
(2015). Werner and colleagues (2016) utilized data from a longitudinal study investigating 
alcohol-related problems and associated psychopathology in order to examine the direction of 
effect between trauma exposure and cannabis use. Specifically, Werner and colleagues (2016) 
examined the contribution of first reported age of onset given for trauma exposures to cannabis 
initiation in an all-female emerging adult twin sample. Results suggest that trauma exposure is an 
important contributor to cannabis initiation and provide support for the self-medication 
hypothesis posited to explain the development of comorbid PTSD-CUD. However, Werner and 
colleagues’ (2016) results are limited by their use of an all-female sample and their reliance on 
retrospective self-report for the longitudinal nature of their study. In another all-female sample, 
Browne and colleagues (2018) examined the independent contributions of sexual trauma on past-
year cannabis use including alcohol and tobacco use as covariates. Cross-sectional results 
revealed that regular cannabis use is common among individuals who had experienced sexual 
trauma, individuals with higher PTSD symptoms, and individuals reporting alcohol or tobacco 
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use. However, Browne and colleagues’ (2018) results are limited by their use of an all-female 
and veteran sample. The current study combined previously supported associations and 
covariates to investigate patterns between trauma exposure and cannabis use.  Overall, the 
current study results reveal that trauma exposure, specifically IPT, may be an important 
contributor to cannabis use, but suggest the importance of considering sex and polysubstance use 
when developing etiologic models of trauma-related phenotypes predicting cannabis use 
phenotypes. 
High-Risk Hypothesis 
 Path analyses did not suggest that cannabis use is a significant predictor of IPT exposure. 
A majority of previous research on the functional relationship between substance use and trauma 
exposure has focused on substances besides cannabis (i.e., alcohol, cocaine) (Brady et al., 1998; 
Kaysen et al., 2006), but limited evidence on the longitudinal relationship between substance use 
and IPT exposure suggests that the misuse of cocaine may be associated with subsequent trauma 
exposure and post-trauma psychopathology (Brady et al., 1998). While the directionality of our 
results from Aim 1 cannot be determined, they demonstrated an association between lifetime 
cannabis use and lifetime IPT exposure similar to other studies examining the functional 
relationship between cocaine use and trauma-related psychopathology (Brady et al., 1998). 
However, our results do not show support for the prospective association between lifetime 
cannabis use potentially influencing new onset IPT exposure. 
 Previous studies examining trauma-related and substance use phenotypes from a high-
risk hypothesis framework found a functional relationship between substance use and trauma 
exposure. For example, Davis and colleagues (2009) examined the effects of alcohol on 
women’s sexual assault risk perception and found that alcohol may increase women’s sexual 
 
 
78 
victimization likelihood through reduced sexual assault risk perception. Studies comparing 
behavioral effects of alcohol and cannabis use found that alcohol use caused more impairment 
than cannabis use at higher doses (Heishman, Arasteh, & Stitzer, 1997; Heishman, Stitzer, & 
Bigelow, 1988). One possible explanation the current study did not find a significant association 
between cannabis use and new onset IPT exposure could be that other substances, such as 
cocaine and alcohol, have more behavioral effects on the body than cannabis use at higher usage 
levels. Another possible explanation the current study did not find a significant association 
between cannabis use and new onset IPT exposure could be due to measurement error. It is 
possible that greater amounts or more frequent cannabis use is associated with a greater 
likelihood of new onset IPT exposure and the way cannabis use was measured in S4S cannot 
differentiate between low and high levels of use. There is a need for both more research on the 
effects of cannabis use on behavior effects and longitudinal studies investigating the effects of 
cannabis use on future trauma exposure. 
Aim 3: Mediational Investigation of the Self-Medication and High-Risk Hypotheses 
Overall Summary of Findings 
 A high rate of comorbidity clearly exists between PTSD and CUD (Bonn-Miller et al., 
2012; Cougle et al., 2011; Kevorkian et al., 2015; Vlahov et al., 2002). Trauma exposure, 
specifically IPT, is highly likely to lead to PTSD; likewise, individuals who engage in substance 
use behaviors have been shown to have a higher likelihood of developing PTSD potentially due 
to an increase in risky behavior compared to individuals who do not engage in substance use 
behaviors (Brady et al., 1998; Chilcoat & Breslau, 1998; Davis et al., 2009). The self-medicating 
relationship between IPT and cannabis use could be mediated by a diagnosis of PTSD and the 
high-risk relationship between cannabis use and PTSD could be mediated by IPT. This study 
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used these etiologic models of comorbid cannabis use and trauma-related phenotypes to 
investigate the mediational relationships between lifetime IPT exposure, probable PTSD, and 
new onset cannabis use, as well as lifetime cannabis use, new onset IPT exposure, and probable 
PTSD during the first two years of college. Although the overall limitations of this study are 
detailed below, two critical limitations relevant to this aim warrant mention prior to 
interpretation of the results. First, a major caveat in the interpretation of these results is that the 
overall model fit was quite poor, which leads to a lack of confidence in the overall model and 
findings. Second, the probable-PTSD assessment is quite poor – consisting of a single item. 
Thus, results should be interpreted with caution. Results of these models did not find significant 
mediation in support of either self-medication or high-risk hypothesis.  
Self-Medication Hypothesis 
 Path analyses suggest a functional relationship between lifetime IPT exposure and 
cannabis use during the first 2 years of college, but that it may not be due to the development of 
PTSD. These results are inconsistent with limited previous research, which suggests that 
individuals who have experienced IPT and developed PTSD may use cannabis to self-medicate 
their distress (Bonn-Miller et al., 2011). Potential reasons for these inconsistent results could be 
due to varying ways of measuring cannabis use and PTSD, as well as mechanisms that better 
explain self-medicating cannabis use. For example, the dichotomous measure of possible PTSD 
used in this study is eliminating the variance that has been shown to exist in other samples 
assessing continuous symptoms of PTSD among cannabis users (Bonn-Miller et al., 2011; Bonn-
Miller, Vujanovic, Feldner, Bernstein, & Zvolensky, 2007). Another reason that our hypothesis 
may have not been supported could be due to the use of an epidemiological sample versus a 
clinical sample. For example, Bonn-Miller and colleagues (2007) used a clinical sample of 
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individuals who all reported meeting DSM-IV-TR PTSD Criteria A1 and A2 for at least one 
lifetime traumatic event and cannabis use in the past 30 days versus S4S’s sample, which is 
representative of the entire VCU student body (Institutional Research and Decision Support, 
2018), which is comparable to the national average of young adults regarding overall diversity 
(i.e., sex, racial/ethnic distribution) (Pew Research Center, 2010). If previous studies have 
documented cannabis use as a self-medicating behavior for PTSD in clinical samples, then it is 
possible that a sample consisting of a majority healthy, some subclinical, and even fewer clinical 
cases would yield different results. Additionally, Bonn-Miller and colleagues (2011) used a 
measure of cannabis use motives in their mediational model in which participants indicated the 
degree to which they used cannabis for a variety of possible reasons (e.g., coping). Although 
there has been an overall push towards the legalization of medical and recreational cannabis use 
in the past decade (Kilmer & MacCoun, 2017), recent research has shown that self-medication of 
mood and anxiety disorders with cannabis is higher in states with medical cannabis use laws 
compared to those without, such as Virginia (Sarvet et al., 2018). It is worth noting that 
medicinal cannabis use was legalized in Vermont in 2004, which could be a confounding factor 
influencing Bonn-Miller and colleagues’ (2011; 2007) results. Given the limited number of 
studies examining cannabis use and PTSD through a self-medication lens, there is a need for 
more longitudinal research on cannabis use as a self-medicating behavior for PTSD in order to 
see if the relationship is specific to clinical populations or if it also applies to the general young 
adult population. 
High-Risk Hypothesis 
 Path analyses do not suggest a functional relationship between lifetime cannabis use, new 
onset IPT exposure, and probable PTSD. Although results did show that more frequent alcohol 
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use was associated with subsequent IPT exposure, results specific to cannabis use as the main 
substance use behavior are inconsistent with previous substance use (i.e., alcohol, cocaine) 
literature that shows individuals who engage in problematic substance use behaviors are more 
likely to experience IPT and develop PTSD (Brady et al., 1998; Davis et al., 2009). One of the 
few studies that longitudinally examined cannabis use as a risk factor for future IPT exposure 
found that cannabis use predicted subsequent sexual victimization and physical assault 
victimization (Martino, Collins, & Ellickson, 2004). However, individuals who experienced IPT 
following cannabis use were also more likely to be involved in other risky behaviors, such as the 
sales of drugs, which could be confounding variables. One of the more recent longitudinal 
studies that investigated cannabis use as a risk factor for prospective IPT exposure combined 
cannabis use with other substance use (i.e., heroin, opiates, cocaine, alcohol) and found a 
positive relationship between substance use and interpersonal violence (Barrett, Teesson, & 
Mills, 2014). Potential explanations for the current study’s inconsistent results could be due to 
measurement differences. For example, the current study did not separate IPT outcomes into 
physical and sexual assault similar to Martino and colleagues (2004) when examining the 
relationship between cannabis use, IPT exposure, and PTSD. Likewise, the current study 
examined cannabis, alcohol, and nicotine use as separate predictors of IPT exposure and PTSD 
unlike Barrett and colleagues (2014). Barrett and colleagues (2014) also used the Clinician 
Administered PTSD Scale (CAPS) to measure PTSD symptoms, which is the gold standard for 
assessing PTSD (Weathers et al., 2018), opposed to a one-item PTSD screener. Interestingly, 
results from this study are more similar to an older study, which found that cannabis users were 
at lower risk for developing PTSD compared to other substance users (i.e., cocaine, 
hallucinogens, alcohol), but at an increased risk for experiencing trauma exposure similar to 
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other substance users (Cottler, Compton, Mager, Spitznagel, & Janca, 1992). Given these 
conflicting results, more research is needed to understand individual-level varying factors that 
influence the complex relationship between cannabis use, IPT exposure, and the development of 
PTSD. 
Limitations 
 Results must be viewed in the context of a number of limitations. First, although college 
students are at a high risk for trauma exposure (Elhai et al., 2012; Overstreet et al., 2017; Scarpa 
et al., 2002; Vrana & Lauterbach, 1994) and cannabis use (Blavos et al., 2017; Johnston et al., 
2016; Suerken et al., 2014), they are a selected population, which may limit the generalizability 
of certain findings. Second, self-reported answers may be subjected to “social desirability” bias 
(i.e., people respond in ways that they think will be viewed favorably), which could influence 
data collection in the areas of illicit and/or illegal substance use (i.e., cannabis, underage 
drinking). Third, the measure used to assess PTSD was a one-item screener tool opposed to a 
diagnostic tool used to verify a clinical diagnosis and thus, rates of diagnosed PTSD are not as 
accurate as they could be. Using a one-item PTSD screener creates a situation where individuals 
who are subclinical and clinical cases are grouped together, which has negative implications in 
the data analysis process. For example, if the relationship between IPT exposure and problematic 
cannabis use is mediated by PTSD for more severe cases, then a PTSD screener would not be 
capable of detecting an effect. A similar limitation also applies to the study’s assessment of IPT 
count, where all IPT exposures are weighted equally in terms of how they could lead to increased 
risk for negative consequences. However, research shows that some forms of IPT are more likely 
to lead to PTSD than others, such as childhood IPT (Hyland et al., 2017), which is not 
specifically measured in the current study. Fourth, while scales assessing coping-related motives 
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behind using licit substances (i.e., alcohol, nicotine) exist [i.e., Drinking Motives Questionnaire-
Revised (Cooper, Russell, Skinner, & Windle, 1992)], no scale exists that measures trauma-
specific coping-related cannabis use motives. A more specific scale will likely enrich the 
research on cannabis use and its impact on the effects of cannabis in humans, specifically using a 
self-medication framework. In order to attain more meaningful results, a standardized assessment 
tool for measuring cannabis use should be created, validated, and utilized in future studies. 
Currently, assessing cannabis use history can be difficult, especially for recreational cannabis use 
due to the lack of a standardized dose, varying levels of THC, and its effect on the body 
regarding the multiple routes of administration (Schauer, King, Bunnell, Promoff, & McAfee, 
2016). Fifth, assessing whether a specified model fits the data is one of the most important steps 
in structural equation modelling (Yuan, 2005). Results from Aim 3 should be interpreted with 
caution due to poor model fit. Lastly, while the longitudinal nature of the Spit for Science data is 
a strength, the current study used the first, second, and third time points, where the second 
timepoint is relatively close to the first (i.e., 6 months). Therefore, there may not be enough time 
between assessments for the development of psychopathology to be detected using the brief 
assessment tools that were a part of Spit for Science, which could be heavily influencing study 
results. Further, only using three of the five time points limits the ability to examine trajectories. 
Future research should utilize more than three time points to further investigate these hypotheses 
and findings. 
Implications and Future Directions 
 The current study identified both risk factors and consequences of cannabis use and IPT 
exposure among college students. Additionally, the current results can serve as a platform for 
future longitudinal studies examining the association between trauma-related and cannabis use 
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phenotypes to build upon. The cross-sectional and longitudinal association between IPT 
exposure and cannabis use remained consistent throughout all aims of the current study, but the 
mediational results regarding the self-medication and high-risk hypotheses may not have been 
supportive of the hypotheses due to confounding effects of individual-level factors that were not 
included in this study (i.e., socioeconomic status, parental income, peer substance use) or this 
study’s broad measurement of clinical characteristics (i.e., problematic cannabis use, PTSD) may 
not be accurate enough to detect significant effects. However, these findings still have clinical 
implications. For example, the association between IPT exposure and subsequent cannabis use 
suggests the importance of trying to create safer college environments, particularly in the early 
stages of college, in prevention efforts aimed at reducing IPT exposure and cannabis use on 
college campuses. Existing work has shown the efficacy of brief interventions (i.e., initiating 
bystander intervention programs, safety escorts) aimed at reducing trauma exposure (Coker et 
al., 2015; Ponsford, 2016); future work should investigate whether such interventions lead to 
decreased cannabis use. Future research should also examine other factors that appear to be 
important in the relationship between IPT exposure and cannabis use, such as polysubstance use 
(Dierker, Braymiller, Rose, Goodwin, & Selya, 2018; Yurasek, Aston, & Metrik, 2017). Future 
investigations into predictors of cannabis use, IPT exposure, and PTSD will assist efforts to 
identify, prevent, and treat students at a greater risk for psychopathology. Previous research has 
convincingly demonstrated that the more students report using cannabis, the more they skip 
classes, have lower GPAs, have enrollment gaps, and do not graduate on time, which are all 
relatively short-term consequences of cannabis use that can have negative long-term effects on 
life trajectory (Arria et al., 2017; Suerken et al., 2016). Regarding short-term risks, any efforts 
made to prevent cannabis use could help improve academic outcomes among college students. 
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Given that results of the current study demonstrate that alcohol and nicotine use frequency is 
positively associated with cannabis use, the more established health risks of alcohol and nicotine 
use (Rehm, 2011; Trofor et al., 2018) could be used as a gateway to build rapport and start the 
conversation about potential health risks of cannabis use using a motivational interviewing 
approach. The general public currently minimizes potential risks of cannabis use (Keyhani et al., 
2018), so by taking a motivational interviewing approach, individuals may begin to realize that 
they may be underestimating potential short- and long-term risks associated with cannabis use. 
The gaps in our understanding of the health effects and safety of regular cannabis use are 
extensive due to the irregularity of the drug and a lack of longitudinal studies. There is a need for 
the continued investment in cannabis use research not only to identify risk and protective factors 
for cannabis use, but to better understand short- and long-term consequences and health effects 
of cannabis use and how to communicate potential risks to the general public, similar to alcohol 
and nicotine use. 
Conclusion 
 Overall, findings support an immediate, small effect of IPT exposure on cannabis use, 
which is preliminary evidence for the self-medication hypothesis. Although evidence for the 
high-risk hypothesis was not found, both etiologic models of comorbid PTSD-CUD should 
continue to be evaluated in other representative samples in order to investigate if and how these 
associations form in other populations. Additionally, findings suggest that measurement error 
could have an impact on the association between IPT exposure and cannabis use given this 
study’s conflicting results with previous studies. The use of more specific assessment tools for 
cannabis use as well as PTSD should be used in future studies in order to investigate the 
etiologic models of comorbid PTSD-CUD. Although current study results should be interpreted 
 
 
86 
with caution due to poor model fit, college mental health centers could screen regularly for 
trauma exposure, PTSD, and behaviors such as substance and alcohol use, which could serve as 
crucial prevention efforts and treatment targets. This preliminary evidence of an association 
between IPT exposure and cannabis use provides an exciting direction for future research, which 
is warranted as cannabis use continues to gain public and legislature support for legalization with 
little longitudinal research to support how it could potentially affect individuals.  
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Appendix 
 
Below are the variable names and their corresponding questions from VCU's Spit for Science 
student survey: 
 
Alcohol use frequency: 
 
 
Cannabis use threshold: 
 
 
 
Nicotine use frequency: 
 
 
 
 
 
 
 
 
 
 
Sex: 
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Race: 
 
 
 
 
 
 
 
 
 
 
 
 
Interpersonal trauma: 
 
 
 
Probable PTSD: 
 
 
